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Morphogenesis of exocrine glands is a complex stepwise process of epithelial ingrowth, ductal elongation, ductal branching, and alveolar
or acinar differentiation. Emerging from an increasing number of mouse gene knockout, dominant-negative, and antisense models is the
identification of a remarkable collection of cell adhesion molecules, growth factors, and their receptors whose time-dependent contributions
to glandular organogenesis are essential. Many have cryptically overlapping and interdependent but noncompensatory roles. Discoidin
domain receptor 1 tyrosine kinase (DDR1) and the ErbB1 receptor of amphiregulin are, for example, required for ductal branching and
elongation. Each is in turn dependent on the Wnt family of morphogenic factors for autophosphorylation or transactivation, respectively.
Here we review the current cast of exocrine glandular morphogens, as a foundation for a global or systems biology appreciation of the
interweaving signaling pathways that underlie mammalian glandular morphogenesis.
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Advances, recent and past, point to organogenesis as a
multifaceted progression of cellular events (Lecuit and Pilot,
2003) involving a subtle and changing paracrine crosstalk of
molecular morphogens. Morphogen crosstalk is in turn
microprocessed (Wiley et al., 2003) in the context of
adhesive forces exerted by adjacent cells and the evolving
extracellular matrix (Affolter et al., 2003; Edlund, 2002;
Gumbiner, 1996; Hogan, 1999; Hogan and Kolodziej, 2002;
Perez-Moreno et al., 2003). Nuclei are profoundly in-
fluenced by both interactions (Bissell et al., 1982), as
manifested at the simplest level in heightened amounts of
local DNA synthesis or apoptosis, and more intricately by a
shifting milieu of transcription factors, transcriptional com-
plexes, (Affolter et al., 2003; Edlund, 2002; Gu et al., 2003;
Hogan and Kolodziej, 2002), and chromosomal modifica-
tions. Such forming cellular communities underlie much of
the physiological success of higher organisms for they offer
specialized responses to altering patterns of environmental
stimuli.0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.05.025
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E-mail address: glaurie@virginia.edu (G.W. Laurie).A well-studied example is the adult mammary gland in
which a complete hormone-dependent developmental pro-
gression is recapitulated with each pregnancy (Bissell and
Barcellos-Hoff, 1987; Hennighausen and Robinson, 1998).
Timed exchange of growth factors from mesenchymal cells
(i.e., inhibin, activin, HGF, EGF) to the morphing epithe-
lium and back (i.e., EGF, FGF3) cross a cell-adhesive
laminin-1- and proteoglycan-enriched basement membrane.
Basement membranes are polymeric sheets capable of both
adsorbing and favorably displaying FGF3 and HGF to
available epithelial receptors—a process subject to continual
basement membrane remodeling by mesenchymal MMPs
(Massova et al., 1998). Cellular ligation of laminin-1, in
turn, is linked to growth factor responsiveness and to
inhibition of a cellular phosphatase making possible prolac-
tin-induced phosphorylation of cytoplasmic Stat-5 and
translocation of Stat-5-phosphate to the nucleus for promo-
tion of milk gene transcription (Lee and Streuli, 1999).
Factors presumed to be morphogenic from cell culture
studies have been recently put to the test via gene knock-
out—an approach that is propelling the organogenesis field
forward at an unprecedented rate. Many genes remain to be
targeted, or alternatively require a conditional knockout
strategy to avoid lethality, and complications can arise from
gene compensation. Nonetheless, application of genetics to
the molecular scrutiny of glandular morphogenesis in vivo
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glandular ‘morphogenetic code’ (Hogan, 1999). Here we
review how mouse gene ablation has begun to clarify many
features of exocrine gland morphogenesis, whose polarized
exocrine secretory cells enjoy an extraordinary level of
investigation at the nexus of mammalian and yeast genetics.
We begin by summarizing key findings in the context of
cellular processes involved in exocrine gland organogenesis.
Six main steps are generally described: (i) primitive epithe-
lial ingrowth, (ii) ductal elongation, (iii) ductal branching,
(iv) acinar or alveolar cell proliferation, (v) acinar or
alveolar cell differentiation, and (vi) acinar or alveolar cell
survival. Each step is dependent on a variably reciprocal
relationship between nascent glandular epithelium and the
underlying mesenchyme.Fig. 1. Glandular morphogenesis begins with primitive epithelial ingrowth.
(a) Schematic view of ingrowth site with interacting epithelial and
mesenchymal cells separated by basement membrane (orange line), a thin,
polymeric, adhesive sheet rich in laminins. (b) Closer view of area boxed in
(a). For simplicity, the basement membrane was excluded. Represented are
cellular adhesion and diffusible factors required for ingrowth, as revealed
by gene knockout. Epithelial (i) PTHLH targets its mesenchymal PTHR1
receptor to promote the survival and differentiation of (ii) FGF10
expressing (Bhushan et al., 2001) mesenchymal cells (see with FGFR2B
receptor). Mesenchymal cells aggregate and adhere to each other via (iii)
cadherin-2 (CDH2; ‘N-cadherin’). Among multiple factors expressed as a
direct or indirect consequence of PTHLH is the transcription factor LEF-1.
Mice lacking LEF-1 fail to develop mammary glands (van Genderen et al.,
1994). Arrows indicate vesicular secretion of PTHLH and FGF10.Forming an exocrine gland in time and space
Primitive epithelial ingrowth, or budding (Hogan, 1999),
is the first outward manifestation of exocrine gland morpho-
genesis (Figs. 1–5). The impressively precise timing and
positioning of an epithelial ingrowth or bud is attributable to
the establishment of overlapping molecular fields that change
through ductal enlongation and beyond. Lacrimal gland
ingrowth in mice is initiated at the eye’s temporal edge at
E13.5 (Makarenkova et al., 2000), whereas salivary gland
budding occurs adjacent to the developing tongue at E11
(Hoffman et al., 2002) or at E10 by both lateral flanks in
mammary glands (Mailleux et al., 2002) or immediately
posterior to the stomach in pancreas (E8.5–E9.5; Golosow
and Grobstein, 1962). Genetic studies suggest that
parathyroid-like hormones FGF10 and cadherin-2 (Fig. 1)
are essential for primitive epithelial ingrowth. Parathyroid-
like hormone is secreted by early mammary bud epithelium
and after release promotes numerous mesenchymal
responses. Most notable is the production of FGF10 (Fig.
1) that triggers epithelial ingrowth (Celli et al., 1998; Govin-
darajan et al., 2000; Mailleux et al., 2002) together with other
factors detailed later. Pancreatic ingrowth is dependent on
mesenchymal aggregation via cadherin-2, as mesenchyme
differentiates to support the epithelium. Restricted fields of
expressed FGF10 are a common feature of budding morpho-
genesis in a number of different organ systems, including
limb bud and lung (Hogan, 1999), and transcription factors
play a key role specifying or restricting this process. Pax 6, for
example, restricts FGF10 responsive epithelia in lacrimal
gland (Makarenkova et al., 2000). Other transcription factors
required for budding include HlxB9, Isl1, LEF-1, Msx1/
Msx2, Pbx1, Pdx1, and Tbx3 (Ahlgren et al., 1997; Daven-
port et al., 2003; Gu et al., 2003; Phippard et al. 1996; van
Genderen et al., 1994).
Ductal elongation (Fig. 2) is dependent on a different
array of adhesive and local diffusible molecules suggestive
of an overlap or switch in molecular signaling strategies.
The recently characterized discoidin domain receptor 1tyrosine kinase (DDR1), which binds collagens, is for
example activated in a Wnt-5a-dependent and pertussis
toxin inhibitable manner. Netrin-1, TIMP1, amphiregulin,
IGF1, the inhibin hB subunit, and leukemia inhibitory factor
are also required. Involvement of TIMP1 emphasizes the
critical importance of basement membrane renewal in epi-
thelial morphogenesis, the former of which is regulated in
large part by relative levels of TIMPs and MMPs. MMP3 is
thought to selectively facilitate ductal elongation and
branching beyond existing basement membranes (Sympson
et al., 1994; Witty et al., 1995) that can otherwise act as a
growth barrier. Yet MMP3 null glands appear essentially
normal despite a transient deficiency in lateral branching
Fig. 2. An elongating duct is formed as epithelial ingrowth progresses (a
and b). (b) Enlarged view of (a) boxed area, with basement membrane
excluded. At least six different cellular adhesion and diffusible factors are
necessary for ductal elongation. (i) Netrin-1 (NTN1) and its receptor
neogenin-1 (NEO1) glue together lumenal and basement membrane
adherent cells. (ii) Epithelial amphiregulin (AREG) and (iii) IGF1,
respectively, target ductal epithelial ErbB1 (EGFR) and IGFR1 receptors.
Some amphiregulin binds mesenchymal ErbB1. IGF1 can also derive in
part from mesenchymal cells. (iv) Inhibin hB subunit (INHBB) and (v) LIF
are mesenchymally derived and bind epithelial receptors. The inhibin hB
subunit targets epithelial type II receptor ActR-IIB (ACVR2B), and LIF
ligates LIFR. (vi) Epithelial DDR1 is a novel collagen receptor with an
affinity for triple helical domains. Arrows indicate release of cell surface
amphiregulin and vesicular secretion of IGF1, inhibin hB, and LIF. Not
shown is TIMP1.
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sation by other MMPs. Netrin-1 was discovered as an
axonal growth protein whose role in glandular morphogen-
esis has received little attention.
Ductal branching (Fig. 3) brings into play a number of
different basement membrane-dependent adhesion mecha-
nisms, as demonstrated genetically by the requirement for
DDR1, integrin a2, a3, and a6 subunits, and cell surface
h1,4-galactosyltransferase. Essential diffusible factors are
more numerous perhaps reflecting the enhanced complexityof branching. These include amphiregulin, BMP7, colony
stimulating factor 1, FGF10, TGFh1-3, and Wnt4. Indian
hedgehog and sonic hedgehog contribute to ductal polari-
zation and mice null for a mediator of hedgehog signaling,
Gli2, display ductal abnormalities (Lewis et al., 2001).
Other key transcription factors include C/EBP h, NF-nB,
and Nkx3.1 (Brantley et al., 2001; Robinson et al., 1998;
Schneider et al., 2000; Seagroves et al., 1998). Some
parallels can be drawn to lung-branching morphogenesis,
which is predicted to balance promotion and inhibition of
new branch sites by relative levels of FGF10, BMPs, SHH,
and Wnts (Hogan, 1999), among other factors.
Acinar or alveolar cell proliferation (Fig. 4) is primarily
under the control of the epithelial mitogens neuregulin 1 of
the ErbB ligand family, tumor necrosis factor ligand super-
family 11 (TNFSF11), and transforming growth factor h1-3.
Also required is IGF2, whose cellular source remains to be
clarified. In keeping with TNFSF11 signaling to NF-nB and
cyclin D1 via IKKa, mice with inactive IKKa subunit or
cyclin D1/ display defective alveolar cell proliferation
(Cao et al., 2001).
Acinar or alveolar cell differentiation (Fig. 5) is triggered
by multiple adhesion and growth factors. Genetic studies
reveal a large role for cell adhesion in acinar or alveolar cell
differentiation, for which laminin receptors figure promi-
nently. Laminin-dependent cell polarization has been ob-
served in multiple cell systems (Yurchenco et al., 2004), but
not fully appreciated are the variety of laminin receptors
required for acinar or alveolar differentiation including
a3h1 and a6h1 integrins, cell surface h1,4-galactosyltrans-
ferase, and the less studied protein tyrosine phosphatase
receptor type F. Other essential players are cadherins-1 and -
3, osteopontin (SPP1), neuregulin1, TGFa, and TGFh 1-3—
all described in more detail later. Key transcription factors
include Hif1a, Id2, Mist1, Nkx3.1, Stat5, and PTF1-p48
(Brantley et al., 2001; Long et al., 2003; Pin et al., 2001;
Seagroves et al., 2003), in keeping for example with the
dependence on Stat5 for laminin-dependent casein expres-
sion (Lee and Streuli, 1999).
Acinar or alveolar cell survival (Fig. 6) like differentia-
tion is largely dependent on the combination of cadherin-1-
mediated cell–cell adhesion, anchorage to laminins through
h1 integrins and protein tyrosine phosphatase receptor type
F, and ErbB4 signaling promoted by CD44. CD44 is a
heparan sulfate proteoglycan that serves to nucleate MMP7
and pro-HB-EGF in the proximity of the ErbB4 receptor on
the apical surface. As essential growth factor coreceptors,
with cell adhesion (and often gel-forming) activity, proteo-
glycans play a large role in morphogenesis and survival.
Exocrine gland morphogenesis is relatively rapid. Ap-
proximately 3–4 days (i.e., lacrimal, prebirth mammary,
pancreas, salivary) or 1 week (pregnant mammary) is
sufficient for ductal elongation (Fig. 2) then branching
(Fig. 3). Five to nine days later, acinar or alveoli have
formed (Hennighausen and Robinson, 1998; Hoffman et al.,
2002; Kratochwil, 1971; Makarenkova et al., 2000; Wessells
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course followed even in vitro (Matter and Laurie, 1994;
Schmeichel and Bissell, 2003; Wessells and Evans, 1968).
Thus, in the short space of 2 weeks or less, unremarkable
stretches of superficial cells seed a tremendous cellular
expansion progressively shaped into a sophisticated secre-
tory factory capable of releasing highly concentrated protein
solutions (several mg/ml) within milliseconds. Viewed by
scanning electron microscopy, secretory acini or alveoli
project from ducts as ball-like or tubular clusters covered
in all dimensions with a basement membrane, which is in
turn ‘spot welded’ with a loosely woven extracellular matrix
containing mesenchymal cells, blood vessels, and nerves.
This three-dimensional snapshot of a microcosm of time and
space obscures the dynamic range of continual cellular and
molecular activity and tissue movement in both the develo-
ping and fully developed exocrine gland. Instructional
exchange sufficiently precise to drive exocrine gland
organogenesis in the three-dimensional adhesive architec-
ture of the developing organism is an amazing feat. At work
are shifting forces both proliferative and antiproliferative orTable 1
Cellular adhesion regulators of exocrine glandular morphogenesis, as suggested by
(Unigene designations indicated)
Role Ligand/Receptor
or enzyme
Gland/Cell
source
Target cell/ECM
protein
N
n
Primitive epithelial
ingrowth
CDH2 P/ms ms d
Ductal elongation DDR1 M/ep COLI-VI, VIII d
NTN1/NEO1 M/ep ep d
TIMP1 M/ep st MMPs d
Ductal branching ITGA M/ep COLI/LAM1 b
ITGA3,6 P/ep LAM1, 5 b
S/ep LAM1, 5 s
DDR1 M/ep COLI-VI m
B4GALT1 M/ep me LAM+ m
Acinar/alveolar ITGA3,6 P/ep LAM1, 5 h
differentiation S/ep LAM1, 5 h
ITGA3 S/ep N/A a
ITGB M/ep ‘ECM’ s
(
CDH1 M/ep ep a
(
d
CDH3 M/me ep p
S/me ep h
B4GALT1 M/ep LAM+ p
PTPRF M/ep ep l
SPP1/ITGAV/ITGB3 M/ep ep l
Acinar/alveolar ITGB M/ep ‘ECM’ a
survival CDH1 M/ep ep a
(
CD44 M/ep ep, sm p
PTPRF M/ep ep a
CDH, cadherin; COL, collagen; DDR, discoidin domain receptor family; ECM, m
ITGA, integrin alpha; ITGB, integrin beta; LAM, laminin; LAM+, laminin plus oth
PTPRF, protein tyrosine phosphatase receptor type F (LAR tyrosine phosphatas
metalloproteinases; M, mammary gland; P, exocrine pancreas; S, salivary gland; ep
stroma.apoptotic, adhesive and anti-adhesive, polymerizing, and
degradative.
An increasing number of mouse gene knockout, domi-
nant-negative, or antisense models have uncovered a re-
markable group of cell adhesion and diffusible effectors of
exocrine gland morphogenesis (Tables 1 and 2). Many have
overlapping roles and influence or are influenced by a
limited array of transcription factors. We next review
genetic data underlying each required ‘cellular adhesion
regulator’ or ‘local diffusible regulator’ in the context of
their protein families. For brevity, particular emphasis is
placed on lacrimal, mammary, and salivary glands and on
the exocrine pancreas. Unigene designations are included
throughout for clarity.Cellular adhesion regulators
Cell–cell and cell-extracellular matrix events are dramat-
ic for they shape cells and tissues and promote responsive-
ness to diffusible factors and hormones. Cell–cell adhesiongene knockout, and/or receptor dominant-negative or antisense approaches
ull factor/Receptor null, or dominant
egative (DN^), or antisense (AS*)
References
orsal but not ventral bud absent Esni et al. (2001)
elayed growth, enlarged terminal end bud Vogel et al. (2001)
isorganized terminal end bud Srinivasan et al. (2003)
ucts somewhat longer* (MMTV promoter) Fata et al. (1999)
ranching less Chen et al. (2002)
ranching less De Arcangelis et al. (1999)
lightly delayed Menko et al. (2001)
ore branching Vogel et al. (2001)
ore branching Steffgen et al. (2002)
ypoplasia De Arcangelis et al. (1999)
ypoplasia De Arcangelis et al. (1999)
pical/basal polarity defects Menko et al. (2001)
omewhat less milk protein^
MMTV promoter)
Faraldo et al. (2001)
lveolar cells dedifferentiate and die
MMTV-LoxP construct); precocious
ifferentiation^
Boussadia et al. (2002)
recocious differentiation then hyperplasia Radice et al. (1997a)
yperplasia Radice et al. (1997b)
recocious differentiation
ate differentiation defects Schaapveld et al. (1997)
ess alveoli and milk* (MMTV promoter) Nemir et al. (2000)
poptosis increased^ Faraldo et al. (2001)
lveolar cells dedifferentiate and die
MMTV-LoxP construct)
Boussadia et al. (2002)
remature involution Yu et al. (2002)
lveolar cells dedifferentiate Schaapveld et al. (1997)
ultiple ECM proteins; B4GALT1, long isoform h1,4-galactosyltransferase;
er substrates; MMP, matrix metalloproteinase; NTN, netrin; NEO, neogenin;
e); SPP1, secreted phosphoprotein (osteopontin); TIMP, tissue inhibitor of
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extracellular matrix adhesion are integrins.
Cadherins-1-3
Cadherins compose a large family of calcium-dependent
transmembrane molecules that ligate like molecules on
adjacent cells (Figs. 1, 5, and 6) to form cellular sheets,
tubes, and mesenchymal condensates. Cadherins were first
discovered via epithelial (Gumbiner and Simons, 1986;
Hyafil et al., 1981; Ogou et al., 1983) or mesenchymal
(Takeichi, 1977) cell aggregation assays. Ligation triggers
phosphorylation of a highly conserved cytoplasmic domain
leading to nucleation of catenin-mediated signaling com-
plexes (Table 3) that alter the actin cytoskeleton, micro-
tubules, and transcription (Perez-Moreno et al., 2003; Yap
and Kovacs, 2003). Gene ablation studies suggest that
cadherins-1, -2, and -3, but not apparently -4, -5, -6, -11,
-15, or -23, are necessary for exocrine gland organogenesis
(Table 1).
Cadherin-2 (CDH2; ‘N-cadherin’) is expressed widely
in pancreas and mammary gland and a number of non-
glandular tissues. Conservation between mouse and human
is high (Table 3). Under normal circumstances, cadherin-2
protein expression is first restricted to mesenchymal cells
(Fig. 1) around the dorsal and ventral pancreatic endoder-
mal ingrowths (E9.5), later spreading to endoderm. When
absent, dorsal mesenchymal cells are lost due to apoptosis.
Although cadherin-2 null ectoderm can develop normally
when transplanted into wild-type host, lacking mesenchy-
mal input, the dorsal bud fails to develop (Esni et al.,
2001). The spared ventral bud is suspected to enjoy
compensation from other unidentified cadherin(s). In con-
trast, cadherins-1 (CDH1; ‘E-cadherin’) and -3 (CDH3; ‘P-
cadherin’) are expressed in epithelial (cadherin-1) or
myoepithelial (cadherin-3) cells and are critical for acinar
or alveolar differentiation (Radice et al., 1997a; Fig. 5).
Both are present in diverse tissues including mammary,
salivary gland, and pancreas and are well conserved (Table
3). Cadherin-1 null embryos die at implantation due to
failure of compaction (Larue et al., 1994; Riethmacher et
al., 1995). However, conditional removal of cadherin-1
solely in mammary gland triggers alveolar cell dedifferen-
tiation and subsequently apoptosis (Boussadia et al., 2002),
suggesting a key role for cadherin-1 signaling. Glands
expressing the dominant-negative h-catenin construct h-
eng are somewhat similar. h-eng remains capable of
interacting with the cytoplasmic cadherin complex but
has amino phosphorylation sites mutated to minimize
degradation and the C-terminal nuclear transactivation
domain replaced by the engrailed repressor to minimize
Wnt/h-catenin signaling (Tepera et al., 2003; see Wnt
section). h-catenin signaling therefore appears to be re-
quired for alveolar cell survival (Tepera et al., 2003).
Dominant-negative cadherin-1 (Delmas et al., 1999) or
absence of myoepithelial cadherin-3 (Radice et al.,1997b) has the opposite effect of promoting alveolar
differentiation in virgin mice, much like an alveolar cell-
expressed h-catenin construct lacking the first 89 amino
acids (Imbert et al., 2001) involved in cadherin binding.
Thus, development of an alveolar-like phenotype is asso-
ciated with availability of active h-catenin or overexpres-
sion of cadherin-1 cytoplasmic domain—both of which
increase alveolar c-myc, cyclin D1, and cadherin-1. Sup-
pressing h-catenin transactivation or ablation of cadherin-1
or the cyclin D1 gene has the opposite effect and triggers
apoptosis. Careful scrutiny of precocious alveoli revealed
some defects suggesting incomplete utilization or expres-
sion of the integrin h1and h4 subunits and laminin-1
(Tepera et al., 2003; see sections below). Organogenesis
is therefore not dependent on one particular factor but
instead on a sampling of different factors in an evolving
contextual setting.
Integrins a2, a3, a6, and b1
Integrins compose the largest family of extracellular
matrix (‘ECM’) receptors (Hynes, 2002). Paired a and h
chains (Figs. 3, 5, and 6) form a ligand binding domain (Luo
et al., 2003) that is cation dependent and whose activity is
reciprocally influenced by C-terminal nucleation of cyto-
plasmic elements, including talin and FAK (Parsons, 2003)
that link integrins to the actin cytoskeleton. Although proxi-
mal nucleation factors differ, both integrins and cadherins
figure strongly in cell proliferation, migration, polarization,
differentiation, and survival by modulating their actin an-
chorage, in large part through a stepwise series of common
GTP or phosphotyrosine-dependent events. Thus, both
receptors sequentially activate Rac1, Cdc42, and the tight
junction complex Par6-PKC~ and inactivate RhoA (Noren
et al., 2003) and glycogen synthase kinase-3h (GSK-3h;
Etienne-Manneville and Hall, 2003)—the latter an intersec-
tion point with the important Wnt or catenin signaling
pathway.
Survey of all integrin gene knockouts indicates key roles
for a2, a3, a6, and h1 integrin subunits in the genesis of
exocrine glands (Table 1). a1, a5, a7, a8, a9, av, aIIb, h4,
h5, and h6 are also all expressed in exocrine glands
(Unigene), and each has been knocked out but glandular
phenotype, if any, is undocumented. Early lethality of a5
and av null necessitates generation of targeted constructs.
Indeed, a5h1 and its ligand fibronectin were recently shown
to modulate salivary gland branching morphogenesis in
organ culture (Sakai et al., 2003).
Pairing of a2 (ITGA2) and h1 (ITGB1) subunits forms
an integrin that binds collagens I and IV at multiple sites
and laminins-1 and -5 via the N-terminus of the a chain.
a2h1 also possibly interacts with aggregated cadherin-1
(Whittard et al., 2002). a2h1 is modestly distributed on
epithelial cells and occasional stromal cells of mammary
gland, pancreas, and other tissues including platelets and
is well conserved between mouse and human (Table 3).
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buds where mammary ducts grow and branch (Fig. 3) and
thereafter gradually diminishes (Keely et al., 1995) with
absence during lactation and involution (Prince et al.,
2002). When a2 is ablated, a substantial reduction in
branching is observed but mice are viable (Chen et al.,
2002). In contrast, a3, a6 (ITGA3, 6), and h1 null mice
die at birth or earlier, in keeping with an apparently much
broader wild-type expression that includes epithelial cells
of mammary, salivary gland, and pancreas. a3 couples
with h1 to bind laminins-2, -5, and -10/11 well at the a
chain C-terminus and laminin-1 poorly. Absence of a3 in
late gestation salivary gland is associated with defects in
basement membrane integrity, acinar cell polarity, and
decreased expression or activation of signaling mediators
RhoA, Cdc42, and ERK1/2 (Menko et al., 2001). ERK 1/
2, JNK (p54/46), Shc (p52/46), Grb2, Akt (P-Thre308),
FKHR (P-Ser256), and Bad (P-Ser136) are similarly
affected by a mammary-targeted dominant-negative h1
construct, possibly in part via an indirect effect on
a6h4 (Faraldo et al., 2001), indicating that mammary
epithelial cells require integrin-mediated adhesion to pro-
liferate via signaling through Shc, Grb2, ERK, and JNK.
Similarly integrin-mediated signaling through Shc, Grb2,
Akt, FKHR, and Bad is required for survival. Yet, late
gestation a3 or a6 null mammary glands transplanted into
wild-type hosts appear to develop normally, despite a
considerable body of in vitro evidence predicting other-
wise (Klinowska et al., 2001). Compensation of one for
the other is highly likely. Indeed a6h1 and a3h1 ligate
essentially identical laminins with the exception that a6h1
also strongly binds laminins-1 and -8 (Colognato and
Yurchenco, 2000). In exocrine pancreas, reduced branch-
ing and aberrant acinar differentiation became apparent
only in a3 or a6 double null mice (De Arcangelis et al.,
1999). a6 is highly conserved (Table 3) and widely
expressed on the basal or basolateral surface of exocrine
epithelia from branching ducts (Fig. 3; Kadoya et al.,
1995) through to mature alveoli or acini (Figs. 5 and 6;
Terpe et al., 1994). The prominence of laminins and
collagens as integrin ligands in glandular morphogenesis
is obvious, yet surprisingly no laminin or collagen chain
knockout has been scrutinized from this perspective.
Knockout of the laminin g1 chain (found in laminins-1,
-2, -3, -4, -6, -7, -8, -9, -10, and -11) and laminin a5
chain (found in laminins-10 and -11) is embryonic lethal
(E5.5 and E14-15, respectively). Neonatal or postnatal
lethality results from removal of laminin a2, the a constit-
uent of laminin-2, or a3 found in laminins-5, -6, and -7.
Similarly, ablation of several collagen chains including the
a1 chain of collagens II, III, VII, and XI; the a2 chain of
collagen V; and the a3 chain of collagen IV is neonatal or
postnatal lethal. The severity of such phenotypes speaks to
the developmental importance of integrin-ECM ligations
(Figs. 3, 5, and 6), for which new dominant-negative and
‘knockout-knockin’ mouse models could hold great promise.Others
A growing number of noncadherin or nonintegrin mol-
ecules have been reported to act on or utilize adhesion-based
mechanisms to direct exocrine glandular morphogenesis.
Gene ablation or suppression of DDR1 (Vogel et al., 2001),
netrin-1 (Srinivasan et al., 2003), and TIMP1 (Fata et al.,
1999), for example, influences ductal elongation. Others
include CD44 (acinar or alveolar cell survival), cell surface
galactosyltransferase (ductal branching; acinar or alveolar
cell differentiation), PTPRF, and osteopontin (acinar or
alveolar cell differentiation; Table 1).
CD44
Some exocrine cells feature the apical cell surface
heparan sulfate proteoglycan CD44 (Fig. 6), which binds
both MMP7 and pro-HB-EGF in a complex with ErbB4
receptor. MMP7-dependent activation of pro-HB-EGF in
the proximity of ErbB4 in turn promotes alveolar cell
survival. MMP7 accumulates basally instead of apically in
CD44/ mice, and although ErbB4 location is unaltered,
phosphorylation on tyrosine is diminished. Also HB-EGF is
only weakly apparent (Yu et al., 2002), and alveolar cells
prematurely enter involution. CD44 is widely expressed in
many different tissues including mammary gland, salivary
gland, and pancreas (Unigene) and is moderately well
conserved (Table 3).
DDR1
Discoidin domain receptor 1 tyrosine kinase (DDR1) is
an interesting new p53-dependent (Ongusaha et al., 2003)
collagen receptor (Curat et al., 2001; Figs. 2 and 3). Its
ligand-dependent autophosphorylation is h1 integrin inde-
pendent (Vogel et al., 2000), yet Wnt-5a dependent (Jonsson
and Andersson, 2001) and pertussis toxin inhibitable (Dej-
mek et al., 2003). Such a phenotype is much different from
any other described collagen receptor. DDR1 is expressed in
mammary gland, salivary gland, pancreas, and other tissues
and is highly conserved between human and mouse (Table
3). Null mice display enhanced collagen deposition and
initially shortened mammary ducts with enlarged terminal
end buds, later compensated by a burst of ductal epithelial
cell proliferation associated with enlarged ductal lumena
and minimal alveolar milk protein (but normal mRNA)
expression (Vogel et al., 2001). This complex dependence
on DDR1, apparently uncompensated by other collagen
receptors, suggests an evolving morphogenic relationship
of epithelial DDR1 with glandular stroma.
b1,4-Galactosyltransferase
With much of the extracellular matrix and cells coated in
oligosaccharides and a history of work illustrating the
importance of cell surface carbohydrates in embryonic
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overexpression of cell surface h1,4-galactosyltransferase
(B4GALT1; Figs. 3 and 5) alters exocrine glandular mor-
phogenesis. Overexpression inhibits (Hathaway and Shur,
1996) and knockout enhances (Steffgen et al., 2002) ductal
branching, leading later in the null to the histological
impression of precocious alveolar differentiation. mRNAs
for laminin a1 (less), a3 (less), g2 (more), and metal-
loproteinases MMP7 and MT1-MMP (both more) are curi-
ously affected. This suggests an intriguing model (Steffgen
et al., 2002) demonstrable in cell culture (Schenk et al.,
2003) in which cleavage of g2 by MT1-MMP releases a
cryptic promigratory EGF-like repeat capable of function-
ally binding EGFR and promoting cell movement (Schenk
et al., 2003). Excision of cell surface glycosyltransferase
could therefore possibly be an early step in stromal-initiated
remodeling at nascent branch points. Cell surface h1,4-
galactosyltransferase is expressed widely in different tissues
including mammary gland and pancreas (Unigene).
Netrin-1
Netrin-1 (NTN1) is a very highly conserved laminin g1
chain homologous protein (Table 3) that guides axonal
growth during development of the central nervous system
(Hedgecock et al., 1990; Tessier-Lavigne et al., 1988).
Recently, a role in epithelial morphogenesis has become
apparent (Salminen et al., 2000) (Fig. 2) in keeping with
peripheral netrin-1 staining of all epithelial cells in terminal
end buds of elongating mammary ducts (Srinivasan et al.,
2003) and presence in salivary gland and pancreas (Unig-
ene). In complementary fashion, netrin-1 receptor ‘neo-
genin’ is restricted to the surface of basement membrane
adherent but motile ‘cap’ cells that form the advancing
ductal boundary. When netrin-1 or neogenin is absent, a
blister develops between cap and prelumenal cells. Distal
segments of the periductal basement membrane and associ-
ated cap cells are also disrupted, but not affected are levels
of cadherins-1 and -3 that respectively bond together pre-
lumenal and cap cells (Srinivasan et al., 2003). An adhesive
interaction between netrin-1 and neogenin that joins both
cell layers (Srinivasan et al., 2003) is occurring (Fig. 3)
though the molecular details have not been fully explored.
Osteopontin
Osteopontin (SPP1) is a widely expressed calcium bind-
ing protein originally isolated from bone that binds av
integrins and CD44. Intact alveolar basement membranes
correlate with transiently high concentrations of alveolar
osteopontin that is moderately low at earlier times (Fig. 5;
Rittling and Novick, 1997). Mice transgenic for an osteo-
pontin antisense construct display abnormally small mam-
mary alveoli and diminished h-casein and whey acidic
protein. A similar phenotype is apparent in vitro when
mammary cells are transfected with the same construct(Nemir et al., 2000). Notably, MMP2 activity in transfectant
cultures is elevated in a manner that correlates inversely
with osteopontin protein expression. In vivo, however, the
two approximately parallel each other with MMP2 first
apparent during mammary ductal elongation, becoming
elevated thereafter through ductal branching and formation
of alveolar buds (Fata et al., 1999). These observations have
lead to the suggestion of a negative regulatory mechanism
whereby high osteopontin levels are sufficient to compete
MMP2 off basal epithelial avh3 integrin (Fig. 5) to which
both osteopontin and MMP2 can bind via RGDS sites. Lack
of cell surface MMP2 in turn diminishes proteolysis of
alveolar basement membranes thereby promoting alveolar
differentiation (Rittling and Novick, 1997).
PTPRF (Lar)
Protein tyrosine phosphatase receptor type F (PTPRF or
‘Lar receptor-like tyrosine phosphatase activity’) displays
features suggestive of an ECM receptor. PTPRF’s fibronec-
tin type III repeats and Ig-like domains (Table 3) help form
the laminin binding extracellular domain. PTPRF can local-
ize to focal adhesions via binding the guanine nucleotide
exchange factor trio (Medley et al., 2003). Interestingly, its
cytoplasmic phosphatase domain (Table 3) is capable of
dephosphorylating h-catenin in complexes with cadherin-1
(Muller et al., 1999). PTPRF is widely expressed in many
different tissues including salivary and mammary glands
(Unigene; Figs. 5 and 6). Much unlike knockout of the
receptor tyrosine kinase DDR1, mice lacking the two
cytoplasmic phosphatase domains of PTPRF have a variable
mammary gland phenotype manifested at the level of
lactation by an apparent alveolar cell exocytotic block
followed by abnormally rapid dedifferentiation (Schaapveld
et al., 1997). The basis for this phenotype is unknown.
Knockout mice display abnormal cholinergic innervation of
the hippocampus and delayed axonal growth after sciatic
nerve crush (Van Der Zee et al., 2003), tentatively suggest-
ing a neuronal defect diminishing regulated glandular se-
cretion that could in turn have negative consequences for
differentiation.
TIMP1
Converging from their respective epithelial or mainly
stromal sources, TIMP1 and MMP3 control the level of
basement membrane discontinuity at the advancing ductal
front without which further growth would be impeded
(Massova et al., 1998). When partially suppressed, via a
transgenic TIMP1 antisense construct controlled by the
mammary MMTV promoter, ductal growth and number is
somewhat enhanced (Fata et al., 1999). The phenotype is
stronger in MMP3 overexpressing mice in which basement
membranes are overtly discontinuous (Witty et al., 1995)—a
growth phenotype inhibitable by simultaneous overexpres-
sion of TIMP1 (Sternlicht et al., 1999). TIMP1 is widely
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pancreas (Unigene), and moderately conserved (Table 3). It
is one of four TIMP family members (Baker et al., 2002)
and can be induced by TGF-h (Edwards et al., 1987; see
diffusible factors below). Absence of TIMP2 has no appa-
rent morphogenic phenotype (Wang et al., 2000), whereas
TIMP3 binds heparin and the glycosaminoglycan domain of
ECM proteoglycans under physiological salt conditions (Yu
et al., 2000) (i.e., perlecan) and when ablated results in
premature involution of the pregnant mammary gland at a
time when it is normally most highly expressed. TIMP3
therefore appears to act as a survival factor (Fata et al.,
2001) in keeping with similar properties observed for
TIMP1 and TIMP2 that are likely distinct from MMPs.
When overexpressed, TIMP3 is apoptotic (Baker et al.,
2002). Notably, mice lacking MMP3 are developmentally
normal with only a transient decrease in lateral branching
(Wiseman et al., 2003) and an accelerated proliferation ofadipocytes during involution (Alexander et al., 2001) ob-
served. Mice lacking MMP2, 7, 9, and 12 also appear
unaltered. Developmental compensation by MMP(s) is
likely at work. However, discreet roles may be distinguished
upon reexamination, as per the recent indications that
MMP2/ mice have a subtle and transient decrease in
ductal elongation and increase in branching (Wiseman et al.,
2003).Local diffusible regulators
Growth factors and adhesion molecules display a re-
markable level of interdependence (Schwartz and Ginsberg,
2002). Extracellularly, adhesion molecules sequester, acti-
vate, and serve as cofactors for growth factor receptor
ligation (Ramirez and Rifkin, 2003). Intracellularly, signal-
ing pathways intersect. At least 13 different growth factors
are required for exocrine gland morphogenesis (Table 2).
Most are epithelially or mesenchymally derived paracrine
factors acting respectively on developing mesenchyme or
epithelia in a sequential trans-basement membrane ‘cross-
talk.’ Others are epithelially derived autocrine factors.
Together, synthesis and release are exquisitely timed.
Amphiregulin, Neuregulin1, and TGFa
Members of the ErbB ligand family are critical for almost
all aspects of exocrine gland morphogenesis including
postnatal ductal elongation and branching (amphiregulin;
AREG; Figs. 2 and 3), acinar cell proliferation (neuregulin1;
NRG1; Fig. 4), and acinar cell differentiation [EGF, neu-
regulin1, and transforming growth factor-a (TGFa); TGFA,Fig. 3. Ductal branching involves at least 10 different adhesion and growth
factors, all primarily secreted by epithelial cells, with the exception of
FGF10. (a) Schematic diagram of duct with distal branching. (b) Distal
branching region enlarged; basement membrane not shown. (i) Epithelial
TGFh1-3 (TGFB1-3) and BMP7 (not shown) of the TGFh superfamily
family act on both epithelial and mesenchymal cells by, respectively,
targeting TGFhRII (TGFBR2) and possibly AcR-II/B (not shown;
ACVR2B, see text). (ii) Epithelially secreted CSF1 is thought to draw
CSF1R bearing macrophages (diagramed) to the subbasement membrane
region where unidentified macrophage-derived growth factors likely
contribute to ductal branching. (iii) Wnt-4 (WNT4) is expressed late in
ductal branching and acts in an autocrine or paracrine manner on the
epithelial Fz (FZD) receptor to signal to the transcription factor LEF1. (iv)
Mesenchymal FGF10 targets the epithelial FGFR2B receptor. (v) Epithelial
amphiregulin (AREG) and (viii) DDR1 signaling are sustained through
respective ligation of EGFR and collagen. (vi) Epithelial a2 (ITGA2), a3
(ITGA3), a6 (ITGA6) integrin, and h1 (ITGB1) subunits are expressed
[here represented by a6h1 bound to the laminin-1 G domain (LAM1;
Mercurio, 2002)]. Binding the same laminin globular domain is (vii) the
long isoform of h1,4-galactosyltransferase (B4GALT1). Laminin and
collagen IV contribute to basement membrane formation by polymerization
(Laurie et al., 1986). Recently, it was suggested that MMP3 null mice are
transiently deficient in lateral branching. Lack of MMP2 may be associated
with a similarly discreet and transient increase in ductal elongation and
decrease in branching, together pointing to a more subtle role for MMPs
(Wiseman et al., 2003).
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mouse salivary gland (Cohen, 1962) where it is highly
expressed. Four homologous receptor tyrosine kinase recep-
tors, ErbB1, ErbB2, ErbB3, and ErbB4, are targeted. They
thereupon form homo- or heterodimers and become phos-
phorylated on cytoplasmic domain tyrosine(s) to initiate a
signal cascade for which ligand-induced internalization
plays a variable and important role (Hendriks et al.,
2003). ErbB-1 (EGFR) is shared by ErbB ligands amphi-
regulin, betacellulin, EGF, epiregulin, epigen, heparin bind-
ing-EGF (HB-EGF), and TGFa. ErbB2 interacts directly
with the EGF-like domain of the Muc4 or sialomucin
complex in mammary and lacrimal glands. This interaction
potentiates neuregulin1 binding (Carraway et al., 1999) and
promotes an apical location for ErbB2 in polarized cells
(Ramsauer et al., 2003). Most ErbB heterodimers contain
ErbB2. Neuregulin1 targets ErbB3 or ErbB4; betacellulin,
epiregulin, and HB-EGF also bind ErbB4 (Harris et al.,
2003). Such receptor sharing offers a remarkable level of
utilizable overlap manifested by severe receptor (Miettinen
et al., 1995; Sibilia and Wagner, 1995; Threadgill et al.,
1995) and mild single ligand knockouts. Heterodimerization
and assembly of cell surface complexes, such as via the
amphiregulin heparin or heparan sulfate proteoglycan bind-
ing domain lacking on EGF or TGFa, enhances ligand
specificity and signaling (Harris et al., 2003).
All EGF family members are secreted as type I trans-
membrane proteins precursors that gain release by specific
MMP- or A-disintegrin and metalloproteinase (ADAM)-
mediated proteolysis. Regulation of shedding is impressive,
as per the previously noted manner by which pro-HB-EGF
is held in a complex with cleaving enzyme MMP7 and
receptor ErbB4 by acinar cell surface CD44 (Yu et al.,
2002). Perhaps even more elaborate is shedding as a
consequence of agonist stimulation. Targeting of the mam-
mary Frizzled (Fz) receptor by Wnt1 or 5a promotes h-
catenin signaling, but also rapid ‘transactivation’ of ErbB1
presumably by MMP mediated release of amphiregulin,
EGF, and/or TGFa (Civenni et al., 2003). Similarly, ligation
of the M3 muscarinic receptor by carbachol transactivates
ErbB1 in different cell types, including exocrine conjuncti-
val goblet cells (Kanno et al., 2003). Unknown is whether
exocrine ErbB1 can be transactivated via the reactive
oxygen series (ROS) pathway as per smooth muscle cells,
a pathway now known to be linked to both integrin and
receptor tyrosine kinase signaling in fibroblasts (Chiarugi et
al., 2003). Gene ablation suggests that amphiregulin, neu-
regulin1, EGF, and TGFa (Table 2) are required for exo-
crine gland morphogenesis, but not apparently HB-EGF and
betacellulin (Jackson et al., 2003). Mice lacking epiregulin
or epigen have yet to be reported.
Amphiregulin, also known as schwannoma-derived
growth factor, is moderately expressed in several different
organs including breast (Unigene). Particularly impressive
are the transiently high levels of expression observed in
mammary terminal end buds when duct development is infull swing (Figs. 4 and 5), and in contrast, the severity of
diminished ductal growth and branching in its absence
(Luetteke et al., 1999). Proliferation and apoptosis are
unaffected, leading some to suggest that ductal cell migra-
tion is impaired (Luetteke et al., 1999) as per amphiregu-
lin’s ability to promote motility in other cell systems
(Gschwind et al., 2003). The glandular phenotype is similar
in ErbB1/ mice, which die at midgestation or as late as
20 days after birth dependent on genetic background
(Sibilia and Wagner, 1995). Also, eyelids fail to fuse, and
the conjunctival sac from which the lacrimal gland develops
is absent (Sibilia and Wagner, 1995). To get around the
problem of perinatal death, combinations of ErbB1/ or
wild-type mammary epithelium or fat pad were grown for 1
month under wild-type renal capsule. Curiously, wild-type
fat pad promoted ductal morphogenesis of ErbB1/ epi-
thelium but not the reverse (Sebastian et al., 1998), even
though ErbB1 is expressed by both cell types (Luetteke et
al., 1999). MMTV-driven epithelial expression (Ahmed et
al., 2002) of dominant-negative ErbB1 lacking much of the
cytoplasmic domain also inhibited ductal branching (Xie et
al., 1997). Suggested therefore is crosstalk between epithe-
lial amphiregulin and mesenchymal ErbB1 (Figs. 2 and 3),
with mesenchyme a precondition for autocrine ErbB1
signaling.
Neuregulin1 (heregulin-a) plays an important role in
alveolar cell proliferation and differentiation and is
expressed in a number of different tissues including mam-
mary gland (Unigene). Neuregulin1 expression by mamma-
ry mesenchymal cells (Figs. 4 and 5) peaks at day 15 of
pregnancy (Yang et al., 1995) and when ablated is associ-
ated with a sharp reduction in alveoli attributable to a similar
decrease in epithelial cell proliferation. Also negatively
affected is h-casein RNA expression, seemingly compen-
sated by a-lactalbumin (Li et al., 2002). Similarly, both
dominant-negative ErbB4 (Jones et al., 1999) and ErbB2
(Jones and Stern, 1999), or conditionally deleted ErbB4
(Long et al., 2003), mice display abnormally small alveoli
and reduced lactation, suggesting that the ErbB4/ErbB2
heterodimer mediates neuregulin1 signaling. Noted in the
ErbB4 dominant negative was lack of tyrosine phosphory-
lation of transcription factor Stat5, in keeping with the
absence of alveoli when Stat5 is ablated (Liu et al., 1997).
Phosphorylation of Stat5 was also less, and lactation altered,
in mice lacking amphiregulin, amphiregulin plus EGF, or
amphiregulin plus EGF and TGFa, suggesting that ErbB1
ligands may contribute to lactation (Luetteke et al., 1999;
Schroeder and Lee, 1998).
CSF1
Colony stimulating factor 1 (CSF1) is widely expressed
at moderately low levels in epithelial cells of the ductal tree
in mammary gland and pancreas and 10-fold higher in acinar
cells of salivary gland (Ryan et al., 2001). The CSF1
receptor (CSF1R) is available on macrophages (Fig. 3)
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uents of the developing lacrimal, mammary, and salivary
glands and of the exocrine pancreas. When radiation-
sensitive macrophages and primary bone marrow-derived
cells are selectively depleted by whole body g-irradiation,
mammary-branching morphogenesis stalls. Subsequent
bone marrow transplantation restores branching. A similar
branching and macrophage deficit is displayed in mammary
glands of mice bearing a deactivating nucleotide insertion in
the coding region of CSF1 (Pollard and Hennighausen,
1994; Gouon-Evans et al., 2000). Normalcy is reestablished
by overexpression of CSF1 (Van Nguyen and Pollard,
2002). These observations have led to the suggestion that
ductal CSF1 attracts migrating macrophages to the periduc-
tal stroma where they release growth factors and/or MMPs
that in turn promote branching morphogenesis (Gouon-
Evans et al., 2000). CSF1 and CSF1R are moderately
conserved (Table 3).
FGF10
Discovery of the 23 member fibroblast growth factor
(FGF) family of multifunctional heparin binding (Raman et
al., 2003) morphogens got its start almost 30 years ago in a
screen for bovine pituitary extracts capable of promoting
fibroblastic 3T3 cell proliferation (Gospodarowicz, 1974),
an activity later found to be widely expressed in other
tissues or cell cultures. At least three of five FGF receptor
(FGFR1-3) genes display tissue-regulated alternative splic-
ing of extracellular domain III to specify FGF binding in a
complex manner that varies among ligand-receptor pairs
and involves heparin-mediated linkage of FGF and FGFR-
heparin binding domains (Ostrovsky et al., 2002). FGF’s
strong affinity for heparan sulfate side chains, which
decorate the core protein of basement membrane proteo-
glycan perlecan, cell surface syndecans, and CD44, con-
tributes importantly to receptor targeting and may represent
a subtle tissue or time-specific control mechanism sensi-
tively regulated by delicate changes in sulfation (Allen et
al., 2001; Knox et al., 2002). Gene knockout studies
suggest that FGF10, but not FGF7, nor apparently FGF1,
2, 3, 4, 5, 6, 8, 9, 14, or 18 are required for exocrine gland
organogenesis.
FGF10, like FGF7 and FGF22, is mesenchymally
expressed and specifically targets epithelial FGFR2B (Figs.
1 and 3). Differing is the strategic distribution of FGF10
expressing cells, which in midgestation lacrimal gland
assembles together like an inverted heating mantle around
surface FGFR2B-positive cells of the growing lacrimal bud
(Makarenkova et al., 2000; Govindarajan et al., 2000). In
contrast, FGF7 expressing cells are absent from the bud
region and are distributed diffusively elsewhere. A similar
pattern is apparent in pancreas, salivary gland, and mam-
mary gland (Dichmann et al., 2003; Hoffman et al., 2002;
Miralles et al., 1999). When FGF10 or FGFR2B are
ablated, exocrine glands either fail to develop (salivary;De Moerlooze et al., 2000; Ohuchi et al., 2000; Revest et
al., 2001) or do so incompletely (pancreas; De Moerlooze
et al., 2000; Ohuchi et al., 2000; mammary; Mailleux et
al., 2002), much in keeping with mice overexpressing a
dominant-negative soluble form of FGFR2 (Celli et al.,
1998). Similarly, lacrimal glands are absent from mice
hemizygous for FGFR2 exon 9 (IIIc), an alteration thought
to cause misexpression of FGFR2B in mesenchyme there-
by interrupting epithelial–mesenchymal interactions and
branching morphogenesis (Hajihosseini et al., 2001). De-
spite its immense role in organogenesis, human FGF10 is
poorly represented in EST databases suggesting low or
discrete levels of expression. More FGF10 ESTs are
apparent in mouse, and FGFR2 is expressed extensively
(Unigene).
IGF1 and IGF2
The complex insulin-like growth factor (IGF) system
composes the widely expressed ligands IGF1 (somatome-
din C) and IGF2 (somatomedin A), the type 1 (IGF1R)
and 2 (IGF2R) insulin-like growth factor receptors, and a
six member, multifunctional IGF binding protein family
susceptible to various proteases including MMPs-1 to -3
(Firth and Baxter, 2002) and ADAMs-9 and -12 (Mohan et
al., 2002). IGF1 and IGF2 mainly target the insulin-
receptor-homologous IGF1R. Soluble, high affinity IGF
binding proteins compete with insulin-like growth factor
receptors for ligand (Payet et al., 2003). This modulatory
mechanism serves to transport IGFs in serum and indi-
rectly couple IGFs with various extracellular matrix mol-
ecules including cell surface heparan sulfate proteoglycans,
fibronectin, and vitronectin. Other IGF binding protein
partners include a5h1 integrin (via RGD site) and the
TGFh type V receptor (Firth and Baxter, 2002). Survey of
all IGF system gene knockouts indicates key roles for
IGF1, IGF2, IGF1R, and the insulin receptor in the
morphogenesis of exocrine glands. Information on IGF
binding protein knockouts is lacking either from absence
of exocrine glandular detail (IGFBP2), not published
(IGFBP5; see Firth and Baxter, 2002), or apparently not
undertaken.
IGF1s diverse tissue distribution includes mammary
gland and pancreas. In mammary gland, it is expressed by
both mesenchymal and epithelial cells to target IGF1R on
epithelial cells of proliferative end buds resulting in ductal
growth (Fig. 2). When ablated, mammary ductal area and
number of terminal end buds were reduced by 94% and
82%, respectively, a deficiency partially treatable with IGF1
but not estrogen or growth hormone (Ruan and Kleinberg,
1999). An identical phenotype was apparent in mice lacking
IGF1R, in which lack of growth could be attributed to
decreased proliferation and not increased apoptosis (Bon-
nette and Hadsell, 2001). Conditional knockout of the
androgen receptor substantially decreases mammary IGF1R
expression resulting in a similar phenotype (Yeh et al.,
Table 2
Local diffusible regulators of exocrine glandular morphogenesis, as suggested by gene knockout, and/or receptor dominant-negative or antisense approaches in
mouse (Unigene designations indicated)
Role Ligand/Receptor Gland/Cell
source
Target
cell
Null factor/Receptor null#, or dominant
negative (DN^), or antisense (AS*)
References
Primitive epithelial
ingrowth
FGF10/FGFR2B H, L/ms ep no gland/bud inhibited* Govindarajan et al. (2000);
Makarenkova et al. (2000)
M/ep, ms ep no gland/no gland# Mailleux et al. (2002)
S/ep? ep no gland^ Celli et al. (1998)
PTHLH/PTHR1 M/ep ms no gland/no gland# Foley et al. (2001);
Wysolmerski et al. (1998)
Ductal elongation AREG/EGFR M/ep ep poor duct growth/poor duct growth^ Luetteke et al. (1999)
IGF1/IGF1R M/st, ep ep poor duct growth and less terminal
end buds
Bonnette and Hadsell (2001);
Ruan and Kleinberg (1999)
INHBB/ACVR2B,
ACVR1B
M/st, ep ep poor duct elongation, alveolar formation Jeruss et al. (2003); Robinson
and Hennighausen (1997)
LIF/LIFR M/ep, st ep poor duct elongation; precocious
alveolar formation
Kritikou et al. (2003);
Schere-Levy et al. (2003)
Ductal branching AREG/EGFR M/ep ms or ep poor duct growth/poor duct growth^ Luetteke et al. (1999)
BMP7/ACVR2B,
BMPR2?
S/ep reduced branching Jaskoll et al. (2002)
CSF1/CSF1R M/ep ma reduced branching Gouon-Evans et al. (2000)
FGF10/FGFR2B P/ms ep reduced branching, Pdx-1 cells Bhushan et al. (2001)
S/ep ep reduced branching or no gland^ Celli et al. (1998); De Moerlooze
et al. (2000); Jaskoll et al. (2002);
Revest et al. (2001)
?/FGFR2C L ? rudimentary mesenchyme but no gland Hajihosseini et al. (2001)
SHH/PTCH S/ep ep reduced branching Jaskoll et al. (2004)
TGFB1-3/TGFBR1, 2 M/ep ep enhanced branching, alveolar formation^ Gorska et al. (1998);
Joseph et al. (1999)
WNT4/FZD M/ep ep reduced ductal branching (transplant) Brisken et al. (2000)
Ductal polarization IHH, SHH/PTCH M/ep ep +/ gives ductal dysplasia Lewis et al. (1999)
Acinar/alveolar IGF2/IGF1R P ep (?) fewer acini/same with double null Kido et al. (2002)
cell proliferation NRG1/ERBB3, ERBB4 M/ms ep few alveoli, little casein Li et al. (2002)
TNFSF11/TNFRSF11A M/ep ep no alveoli/no alveoli# Fata et al. (2000)
TGFB1-3/TGFBR1, 2 P/ep ep acinar proliferation, dedifferentiation^ Bottinger et al. (1997)
Acinar/alveolar
differentiation
NRG1/ERBB3, ERBB4 M/ms ep few alveoli, little casein/small alveoli,
casein but no lactalbumin^
Li et al. (2002)
TGFA/EGFR M milk protein altered Luetteke et al. (1999)
TGFB1-3/TGFBR1, 2 P/ep ep acinar proliferation^, dedifferentiation Bottinger et al. (1997)
Acinar/alveolar survival TNFSF11/TNFRSF11A M/ep ep no alveoli/no alveoli# Fata et al. (2000)
ACVR1B, activin receptor type IB (‘ActR-IB’ or ‘ALK4’); ACVR2B, activin receptor type IIB (‘ActR-IIB’); AREG, amphiregulin; BMP, bone morphogenetic
protein; BMPR, bone morphogenetic protein receptor; CSF, colony stimulating factor; CSF1R, colony stimulating factor 1 receptor; EGFR, epidermal growth
factor receptor (erythroblastic leukemia viral oncogene homolog M; ‘ErbB1’); ERBB3, 4, erythroblastic leukemia viral oncogene homolog 3, 4 (‘ErbB3, 4’);
FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor; FZD, Frizzled homolog; INHBB, inhibin hB; IGF, insulin-like growth factor; IGFR,
insulin-like growth factor receptor; IHH, Indian hedgehog; LIF, leukemia inhibitory factor; LIFR, leukemia inhibitory factor receptor; NRG1, neuregulin1;
PTCH, patched homolog; PTHLH, parathyroid hormone-like hormone; PTHR1, parathyroid hormone receptor 1; SHH, sonic hedgehog; TGFB, transforming
growth factor beta; TGFBR1, transforming growth factor beta receptor 1 (‘TGFhRI’); TGFBR2, transforming growth factor beta receptor 2 (‘TGFhRII’);
TNFSF, tumor necrosis factor (ligand) superfamily; TNFRSF, tumor necrosis factor receptor superfamily; WNT4, wingless-related MMTV integration site 4;
H, Harderian gland; L, lacrimal gland; M, mammary gland; P, exocrine pancreas; S, salivary gland; ep, epithelium; ma, macrophage; me, myoepithelium; ms,
mesenchyme; sm, smooth muscle; st, stroma.
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pancreas where development of the exocrine, but not
endocrine, component is greatly diminished in IGF1/ or
IGF2/ mice as a result of decreased proliferation. Mice
double null for IGF1R and the insulin receptor, but not
single null for each, were similarly affected. Since IGF1
family member IGF2 can uniquely target both receptors and
displays a similar phenotype when ablated, it seems likely
that IGF2 (Fig. 4) may be key for the exocrine pancreas
(Kido et al., 2002). IGF2 is expressed in pancreas, mam-
mary gland, and multiple other tissues.Indian or sonic hedgehog (IHH/SHH)
The hedgehog (Hh) family of morphogens are tethered
in part to basement membrane and cartilage (Gritli-Linde et
al., 2001) perlecan in a heparin-independent manner (Park
et al., 2003). Hedgehogs were discovered in Drosophila
(Nusslein-Volhard and Wieschaus, 1980). Vertebrates have
three family members including desert hedgehog (Dhh;
DHH), Indian hedgehog (Ihh; IHH), and sonic hedgehog
(Shh; SHH). Dhh, Ihh, and Shh display similar structural
domains (Table 3) and functions. Hedgehogs display a C-
Fig. 4. Acinar or alveolar cell proliferation requires TNFSF11, neuregulin
(NRG1), IGF2, and TGFh1-3 (TGFB1-3). (a) Distal end of duct, with
boxed cell enlarged in (b), without basement membrane. (b) Required
mitogens are almost all of epithelial origin. (i) Epithelial TNFSF11 is a
trimeric type II membrane protein, which targets the epithelial receptor
TNFRSF. (ii) Neuregulin1 secreted by mesenchymal cells ligates epithelial
ErbB3 (ERBB3) and ErbB4 (ERBB4). Cellular source of (iii) IGF2 remains
to be clarified but likely ligates epithelial IGF1R. (iv) Epithelial TGFh1-3 is
essential.
Table 3
Human or mouse protein sequence identities and domain structures of
adhesion and local diffusible regulators
Ligand/Receptor
or enzyme
Protein
core
MW
(kDa)
Hu/Ms
protein
identity
(%)
Identical
amino
acids
Domains
ACVR1B 56.8 98 505 TM, GS, S_TK
ACVR2B 57.6 98 512 TM, S_TK
AREG 27.9 69 252 EGF, TM
B4GALT1 43.8 86 397 TM
BMP7 49.3 97 431 TGFB
CD44 81.6 77 361 LINK, TM
CDH1 97.5 81 882 CA, TM
CDH2 99.9 96 906 CA, TM
CDH3 91.4 81 829 CA, TM
CSF1 60.1 70 553 TM
CSF1R 108 74 969 IG, IGC2, TM, TK
DDR1 101.1 93 875 DS, TM, TK
DHH 43.6 96 396 HINT
FGF10 23.4 93 208
FGFR2 92 97 821 IGC2, TM, PK
IGF1 15.2 93 127 INS
IGF2 20.1 83 180 INS
IHH 45.3 95 317 HINT
INHBB 45.1 96 407 TGFB
ITGA2 129.3 82 1181 INTA, VWA, TM
ITGA3 118.7 87 1051 INTA, TM
ITGA6 126.6 92 1073 INTA, TM
ITGB1 88.4 92 798 PSI, VWA, TM
LIF 22 79 202 FN3, TM
NTN1 67.7 98 604 LAMNT, EFGLAM,
C345C
NRG1 70.3 88 296 IGC2, EGF, TM
PTHLH 20.2 88 171
PTPRF 211.7 94 1907 IGC2, FN3, TM, PTP
SHH 49.6 87 462 HINT
SPP1 35.4 59 300
TIMP1 23.2 74 202 C345C
TGFB1 44.3 89 391 TGFB
TGFB2 47.7 95 414 TGFB
TGFB3 47.3 97 410 TGFB
TNFSF11 35.5 84 317 TNF, TM
TNFRSF11A 66 67 615 TNFR, TM
WNT4 39.1 98 351 WNT
Percentage of protein identity and amino acids identical from Unigene.
Protein core molecular weight from EMBL Bioinformatic Harvester.
Protein domains from Human Protein Reference Database. CA: cadherin
repeats; C345C: netrin C-terminal domain; DS: discoidin domain; GS: GS
motif; EGF: epidermal growth factor-like domain; EGFLAM: laminin-type
EGF-like domain; FN3: fibronectin type 3 domain; HINT: hedgehog/intein
domain; IG: immunoglobulin; IGC2: immunoglobulin C-2 type; INS:
insulin/insulin-like growth factor family; INTA: integrin alpha (beta-
propeller repeats); LINK: link (hyaluronan binding); LAMNT: laminin N-
terminal domain; PSI: domain found in plexins, semaphorins, and integrins;
PK: protein kinase; PTP: protein tyrosine phosphatase; S_TK: serine/
threonine protein kinase; TGFB: transforming growth factor-beta family;
TKc: tyrosine protein kinase; TM: transmembrane domain; TNF/TNFR:
tumor necrosis factor/receptor family; VWA: von Willebrand factor type A
domain; WNT: domain found in wingless/int family.
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internally cuts the molecule in half and adds a hydrophobic
cholesterol moiety on the C-terminus of the released
morphogenic N-terminal fragment. In addition, palmitoyla-tion of the hedgehog N-terminus enhances activity but not
receptor binding (Pepinsky et al., 1998). Palmitoylation
together with cholesterol makes for a highly lipophillic
fragment thought by some to be restricted to short range
morphogenic action, whereas experimentally it is clear that
the unmodified fragment diffuses freely but patterns abnor-
mally (Porter et al., 1996). How hedgehogs form long
range morphogenic gradients (Gritli-Linde et al., 2001) is
not well understood. Gradient formation is thought to
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(Disp) that, like the hedgehog receptor ‘patched 1’ (Ptc1;
PTCH), contains a sterol sensing domain (Kawakami et al.,
2002). Both Ptc1 and Disp are morphologically thought to
resemble ion channels or transporters. The role of perlecan
is not well integrated with these models. Perlecan is
required for hedgehog signaling (Park et al., 2003) and
could contribute via its cell proximal location to gradient
formation and presentation of hedgehog to patched possibly
through candidate tethering sites in domain IVs hydropho-
bic stretch or domain II LDL receptor class A homologies
(Noonan et al., 1991; Murdoch et al., 1992; Laurie et al.,
1982). Other studies point to the heparan sulfate transferase
‘EXT1’ as being involved in proteoglycan-dependent ag-
gregation and target cell diffusion of hedgehog (Gallet et
al., 2003). Alternatively, it is the rate of hedgehog diffusion
(Dillon et al., 2003) that is key to long range gradient
formation.
Hedgehog signaling occurs in an unusual manner via the
G-protein coupled receptor-homologous protein ‘Smooth-
ened’ (Smo) when hedgehog ligates the 12 pass transmem-
brane receptor Ptc1 or its homolog Ptc2. Subsequent
downstream signaling targets the Gli1 family of transcrip-
tional activators that in turn promotes the expression of
Ptc1 and Hip genes. Hip codes for a cell surface type I
transmembrane protein that competes with Ptc1 for hedge-
hog (Chuang and McMahon, 1999) and when absent affects
the endocrine but apparently not the exocrine pancreas
(Kawahira et al., 2003). Curiously, in neuroepithelium
and likely elsewhere, unoccupied Ptc1 promotes apoptosis
(Thibert et al., 2003). Dependent on situation, an important
developmental interrelationship exists between hedgehogs
and FGFs, PTHrP, TGFhs, and Wnts. For example, noto-
chordal activin hB and FGF2 inhibit Shh expression—a
prerequisite for pancreas development (Hebrok et al.,
1998). Hedgehog signaling elements are well represented
in exocrine glands (Hebrok et al., 2000; Jaskoll et al., 2004;
Lewis et al., 1999; Unigene), that is, Dhh, Ihh, Ptc1, Dvl2
(mammary gland, pancreas), Shh, Ptc2, Disp (mammary
gland), Smo, Dvl1 (mammary and salivary gland, pancre-
as), Shh, Ptc1, and Smo (salivary gland). In mammary
gland, Ihh and Ptc1 are primarily localized to ductal and
alveolar epithelia with some Ptc1 stromal expression (Lewis
et al., 1999). Since absence of Ptc1 (Goodrich et al., 1997)
or both Ihh and Shh (Ramalho-Santos et al., 2000) is early
embryonic lethal and absence of Shh alone is late embry-
onic lethal, attention has been paid to Ptc1+/ mammary
glands and transplantation of Ihh/ and Shh/ mammary
epithelia into wild-type stroma. Ptc1+/ glands display a
very modest hypercellularity of ductal epithelia, later cor-
rected (Lewis et al., 1999); whereas single hedgehog nulls
appear normal (Gallego et al., 2002). It is thought that Ihh,
Shh (Michno et al., 2003), and possibly Dhh can compen-
sate for one another in mammary development since
expression of Ihh and Shh (and partially Dhh) is over-
lapping (Lewis et al., 1999) and all three factors ligate Ptc1.E18.5 salivary gland from Shh/ mice, however, displays
much reduced branching (Jaskoll et al., 2004). Ablation of
transcription factor Gli2 to which hedgehogs signal leads to
misshapen mammary ducts, some with wide lumena (Lewis
et al., 2001).
Inhibin b, BMP7, and TGFb 1–3
Central to exocrine glandular morphogenesis are sev-
eral members of the transforming growth factor h
(TGFh) superfamily of inhibins or activins, TGFhs,
nodal, bone morphogenetic factors (BMPs), Mullerian-
inhibiting substance (MIS), and growth and differentiation
factors (GDFs). The TGFh superfamily is remarkably
integrated into the cellularized polymeric gels that seed
new exocrine glands. Playing into this role are corecep-
tors and extracellular ‘ligand traps,’ a propensity by
TGFhs to trigger deposition of new extracellular matrix;
and cellular microprocessing of these and other influences
that make TGFh action very dependent on context (Shi
and Massague, 2003). Serving as coreceptors are the
moderately expressed transmembrane heparan sulfate pro-
teoglycan ‘betaglycan,’ the EGF and cysteine-rich CFC
domain protein Cripto (TDGF1), and the RGD bearing
homodimeric type I integral membrane protein endoglin.
Betaglycan (transforming growth factor beta receptor III;
TGFBR3) displays typical proteoglycan multifunctionality.
Not only does it bring TGFh1,3 and inhibins into
receptor proximity via binding domains on its core
protein in a manner that can enhance affinity for receptor
(Esparza-Lopez et al., 2001), it also serves as a corecep-
tor for FGFs, which are drawn to its free heparan sulfate
side chains. In contradistinction, ligand traps sequester
away and/or inactivate TGFhs from target cells. Exam-
ples include the collagen binding small leucine-rich
proteoglycan decorin (Kresse and Schonherr, 2001),
latency-associated protein derived from the precursor
form of TGFh (De Crescenzo et al., 2001), and folli-
statin. TGFh superfamily receptors are serine or threonine
kinases (Table 3), designated as either type I or II by
homology (i.e., ACVR1B, ACVR2B). Preferential ligand
binding by one type promotes dimerization with its
opposite pair and activation of downstream Smad’s (Lee
et al., 2003), a pathway directed towards nuclear tran-
scription (Shi and Massague, 2003). Gene knockout
experiments suggest that inhibins or activins containing
the inhibin hB subunit (INHBB), as well as BMP7 and
TGFh1-3 (TGFB1-3), are required for exocrine glandular
morphogenesis. Not apparently contributing are Mullerian
inhibitory substance, BMP3, BMP6, BMP8, BMP15,
GDF9, nodal, and activin A.
The inhibin hB subunit is constitutively expressed
throughout mammary development (Jeruss et al., 2003;
Robinson and Hennighausen, 1997) and in salivary gland
(Unigene). Pancreatic expression is barely detectable at
E12 but rises steadily thereafter (Dichmann et al., 2003),
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gon-positive epithelial cells destined for the endocrine
lineage (Maldonado et al., 2000). When absent in mam-
mary gland, ducts fail to fully lengthen, terminal end buds
are retained, and alveolar formation is impeded. All three
deficiencies are rescuable by transplantation of null epithe-
lia into wild-type fat pads but not wild-type epithelia intoFig. 5. Multiple adhesion and growth factors promote acinar or alveolar cell
differentiation. (a) Depiction of forming acinus or alveolus at distal end of
duct with differentiating secretory cells distinguished by apical secretory
granules. Nearby are nerve termini. (b) Two secretory cells from boxed area
in (a) with required morphogens depicted. Basement membrane was
excluded for simplicity. Cadherin-3 (CADH3; P-cadherin, not shown) and
(i) cadherin-1 (CADH1; E-cadherin), respectively, form myoepithelial–
epithelial and epithelial–epithelial linkages, the latter going hand-in-hand
with tight junction formation (not illustrated). (ii) Epithelial osteopontin
(SPP1) is thought to compete with MMP2 for ligation of the avh3 integrin
receptor (ITGAV/ITGB3), with less epithelial-bound MMP2 reducing
basement membrane remodeling. (iii) Epithelial neuregulin1 (NRG1) and
(v) TGFh1-3 (TGFB1-3) continue to play a key role. (iv) The epithelial
tyrosine phosphatase PTPRF appears to bind laminin a chains. (vi)
Epithelial a6h1 integrin (ITGA6/ITGB1) and (vii) the long isoform of
h1,4-galactosyltransferase (B4GALT1) bind the laminin-1 (LAM1) G
domain. Ablation of ErbB4 in mammary gland greatly negates Stat5
activation, thereby diminishing cell proliferation and alveolar formation
(Long et al., 2003). Stat5 nulls have a similar phenotype (Liu et al., 1997).
Little attention has been paid to differentiation of exocrine secretory
pathways (Castle et al., 2002).null fat pads (Robinson and Hennighausen, 1997), suggest-
ing that the highly conserved inhibin hB subunit (Table 3)
in mammary gland is mesenchymally derived (Fig. 2)—
much like FGF10 (primitive epithelial ingrowth) and neu-
regulin (acinar or alveolar differentiation) discussed earlier.
Later, the source of inhibin hB appears to be primarily
epithelial, in keeping with a presumed switch to autocrine
signaling (Jeruss et al., 2003). Inhibin hB contributes to
inhibin B (dimer of inhibin a and hB), activin AB (dimer
of inhibin hA and hB), and activin B (dimer of inhibin
hB). All target the epithelial type II receptor ‘ActR-IIB’
(ACVR2B) but display differential recruiting of the type I
receptor ‘ActR-IB’ (ACVR1B, also known as ‘ALK4’;
only activins). Betaglycan binds inhibins and TGFh (Lewis
et al., 2000; Chapman et al., 2002). Follistatin binds
activins, BMP2,4,7, and GFD5. Each receptor is very
highly conserved (Table 3) and moderately expressed
(Unigene). Strong phenotypes result when ablated. For
example, in ActR-IIB/ mice, the pancreas is much
smaller (Kim et al., 2000).
BMP7 was originally isolated as an osteogenic factor
from bone (Ozkaynak et al., 1990). BMP7 is now known to
be expressed widely in multiple different tissues including
pancreas (Dichmann et al., 2003), breast (Unigene), and in
ductal epithelia and some mesenchymal cells of the salivary
gland (Jaskoll et al., 2002; Hoffman et al., 2002). Salivary
gland BMP7 mRNA gradually decreases from maximum at
midgestation (Hoffman et al., 2002), suggesting a very tight
window of developmental expression, whereas only a slight
increase in pancreatic expression is observed from early to
late gestation (Dichmann et al., 2003). Reduced salivary
branching and a disorganized mesenchyme have been noted
in BMP7 knockout mice (Jaskoll et al., 2002). An ActR-IIA
dominant-negative construct displays a very modest exo-
crine pancreas phenotype (Shiozaki et al., 1999), possibly
suggesting that the primary BMP7 receptor pair is ActR-IIB
or BMPR-II (Shi and Massague, 2003) rather than ActR-IIA.
The TGFh1-3 isoforms are epithelially expressed and
target epithelial ductal and mesenchymal ThR-II (Crisera et
al., 2000) of the ThR-II/ThR-I (TGFBR2/TGFBR1) recep-
tor heterodimer (Figs. 3–5). Each appears in an overlapping
but slightly differing manner in mammary terminal end buds
with TGFh1 seemingly elevated in virginal and early
pregnant glands but decreased thereafter. In contrast,
TGFh2 and 3 are maximal at midpregnancy (Robinson et
al., 1993). Similarly, ductal morphogenesis and TGFh1
expression go hand-in-hand in the developing exocrine
pancreas and salivary gland (Jaskoll and Melnick, 1999).
Expression peaks in pancreatic acini at birth (Crisera et al.,
2000) and continues to be expressed later (Kulkarni et al.,
1993) together with lesser levels of pancreatic TGFh2 and
TGFh3 (Yamanaka et al., 1993). Unknown is the amount of
available active isoforms (Barcellos-Hoff and Ewan, 2000),
for much becomes trapped in the extracellular matrix
(Silberstein et al., 1992). When individually ablated, the
results are suggestive of compensatory up-regulation. E18.5
Fig. 6. Acinar or alveolar cell survival factors. (i) CD44 is an apically
located heparan sulfate proteoglycan (shown), which complexes with
ErbB4 and pro-HB-EGF (not depicted). Different isoforms and distribu-
tions of CD44 are created by alternative splicing and partial proteolysis
(Cichy and Pure, 2003). (ii) Epithelial cadherin-1 (CDH1), (iii) PTPRF, and
(iv) h1 integrins (ITGB1) are individually required for acinar or alveolar
cell survival.
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–22 15salivary glands from mice lacking TGFh2 or TGFh3
(Jaskoll and Melnick, 1999), and 7- to 30-day salivary
gland or exocrine pancreas from TGFh1/ mice (Boivin
et al., 1995; Kulkarni et al., 1995), appear to develop
normally even though exocrine glands and other tissues of
TGFh1/ mice are subject to severe autoimmune disease
(Kulkarni et al., 1993). More informative are TGFh over-
expression and receptor dominant-negative models. TGFh1
overexpression driven by the epithelial MMTV promoter
suppressed enlargement of the mammary ductal network
(Pierce et al., 1993). The opposite was true with a dominant-
negative ThR-II receptor construct also driven by MMTV;
and alveolar formation was enhanced (Gorska et al., 1998).
When TGFh1 overexpression occurred later—via the epi-
thelial whey acidic protein promoter—alveolar formation
and milk secretion were diminished (Jhappan et al., 1993).
Even later, dominant-negative ThR-II receptor expression in
pancreatic acinar cells [metallothionein-like (MT) promoter
with zinc] triggered acinar to ductal cell dedifferentiation,
acinar cell apoptosis, and proliferation and increased mac-
rophagic infiltration (Bottinger et al., 1997). The latter bears
receptors for the ductal branching mitogen CSF1 (Gouon-
Evans et al., 2000), as discussed above. Together these datapoint to the importance of TGFh signalling through epithe-
lial ThR-II or ThR-I in the negative regulation of ductal
branching and alveolar or acinar formation. Suggested
additional roles in acinar cell differentiation and survival
appear contradictory but are a reminder of likely linkages to
other factors. For example, dominant-negative ThR-II ex-
pression in periductal mammary stromal cells sparks in-
creased branching in a manner associated with increased
hepatocyte growth factor (HGF) but not MMP2, MMP3, or
IGF1 expression (Joseph et al., 1999). HGF is a widely
expressed morphogen (Unigene) that promotes branching
morphogenesis in vitro. Absence from Table 2 reflects lack
of a living genetic model due to early lethality (Birchmeier
and Gherardi, 1998) and no apparent conditional models
relevant to exocrine morphogenesis.
LIF
Leukemia inhibitory factor (LIF) is an EGF and TGFh
inducible (Schluns et al., 1997) member of the IL6 cytokine
family with multiple functions. LIF is present in many
tissues (Unigene). When overexpressed in endocrine pan-
creas, LIF promotes a noradrenergic to cholinergic neuro-
transmitter switch in sympathetic neurons innervating islets
(Bamber et al., 1994) and promotes the differentiation of
mouse corticotrophs by triggering a G1/S cell cycle block
and enhancing ACTH secretion (Stefana et al., 1996).
Comparatively, little is known of its role in exocrine
morphogenesis. Analysis in mammary gland reveals a
biphasic RNA expression pattern with peak levels in virgin
or pregnant and involuting glands and little during lactation
(Kritikou et al., 2003; Schere-Levy et al., 2003). When
ablated, ductal growth is impaired and alveoli precociously
appear, the latter underscored by a dramatic decrease in
phosphorylated ERK1/2, and increase in phosphorylated
Stat5 and expression of h-casein (Kritikou et al., 2003).
Presence of LIF therefore promotes ductal growth (Fig. 2)
and negatively regulates alveolar formation.
PTHLH (PTHrP)
Parathyroid hormone like hormone (PTHLH) promotes
the survival and initial differentiation of FGF10 expressing
mesenchymal cells in mammary gland. PTHLH is an 18-
kDa factor identified originally in a human lung cancer
cDNA library (Moseley et al., 1987) and independently in a
search for a cDNA underlying human malignant hypercal-
cemia (Suva et al., 1987). Diffusion of epithelially
expressed PTHLH from the preformed mammary bud
targets parathyroid hormone receptor 1 (PTHR1) on sur-
rounding mesenchymal cells (Fig. 1) to in turn stimulate
androgen receptor expression necessary for androgen-
dependent apoptosis of buds in males. Also stimulated are
the large antiadhesive ECM component tenascin C,
h-catenin, the LEF-1 transcription factor (Dunbar et al.,
1999; Foley et al., 2001), and mesenchymal factors. To-
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ation and ingrowth and promote epithelial expression of the
proliferation, differentiation, or survival factor TNFSF11
(Fata et al., 2000; see below). When either PTHLH or
PTHR1 are ablated, androgen receptor, tenascin C, h-
catenin, and LEF-1 fail to be appropriately expressed and
epithelial buds degenerate—a condition largely reversible
by crossing PTHLH/ mice with PTHLH overexpressors
(Wysolmerski et al., 1998). A similar phenotype is observed
in the LEF-1 knockout mouse (van Genderen et al., 1994).
Augmentation of h-catenin and LEF-1 points to a reappear-
ing morphogenetic dependence on the Wnt or catenin
signaling pathway about which we further discuss in the
Wnt section below. Gaining little attention in exocrine
morphogenesis is the potential contribution of angiogenesis,
which PTHLH is capable of inhibiting via a protein kinase-
A-dependent pathway (Bakre et al., 2002). Human PTHLH
is expressed in pancreas and mammary gland, among other
tissues including endochondral bone (Unigene), and is
moderately well conserved (Table 3).
TNFSF11 (RANKL)
Tumor necrosis factor ligand superfamily member 11
(TNFSF11) is denoted by several descriptive names and
acronyms including ‘receptor activator of nuclear factor
kappa b ligand’ (RANKL), ‘TNF-related activation-
induced cytokine’ (TRANCE), ‘osteoprotegerin ligand’
(OPGL), and ‘osteoclast differentiation factor’ (ODF).
Such terminology reflects TNFSF11s primary role as a
bone cytokine (Boyle et al., 2003; Khosla, 2001).
TNFSF11 is a trimeric (Ito et al., 2002) type II membrane
protein, cleavable in part to a smaller soluble form. Both
membrane and soluble forms are active. Identification was
achieved via a screen for the ligand of the TNF receptor-
like protein TNFRSF11B (osteoprotegerin, OPG; Simonet
et al., 1997; Yasuda et al., 1998) now known to be a key
TNFSF11 antagonist since it lacks a transmembrane do-
main and is soluble. The true TNFSF11 receptor is
TNFRSF11A, also known as RANK (Nakagawa et al.,
1998), a type I transmembrane protein somewhat less well
conserved than TNFSF11 (Table 3), but via which multiple
signaling cascades are triggered in a TRAF6-dependent
manner (Boyle et al., 2003). Both ligand and receptor are
coexpressed (Fig. 4; Fata et al., 2000); and in mammary
ductal and alveolar cells, TNFSF11 expression is inducible
with progesterone, prolactin, and PTHLH, but not estrogen.
TNFSF11 antagonist TNFRSF11B is also expressed in
mammary gland and pancreas (Unigene), suggesting that
mammary gland contains the complete TNFSF11,
TNFRSF11A, or TNFRSF11B system. Alveoli are lacking
from mice null for TNFSF11 or TNFRSF11A, a result
likely caused by enhanced alveolar cell apoptosis from
suppressed Akt activation (Fata et al., 2000). TNFSF11
also stimulates expression and nuclear translocation of the
transcription factor C/EBP h. C/EBP h binding sites arewell represented in the h-casein gene promoter and are
required for TNFSF11 stimulation as revealed by TNFSF11
unresponsiveness when C/EBP h sites are mutated (Kim et
al., 2002). Notably, mice lacking the C/EBP h gene display
impaired alveolar development (Robinson et al., 1998;
Seagroves et al., 1998).
Wnt-4
Discovery of Wnts (WNT; wingless-type MMTV inte-
gration site) and their important developmental role as
ligands (Bhanot et al., 1996) for the Frizzled [Fz (FZD);
Vinson et al., 1989] family merged the fields of mammary
oncogenesis with Drosophila developmental genetics. Wnt1
was identified in a screen for genes insertionally activated
by mouse mammary tumor virus (MMTV) and accordingly
is not normally expressed in lactating mouse mammary
gland (Nusse and Varmus, 1982). Wnt-1 protein homology
to the Drosophila wingless gene product was appreciated
several years later (Cabrera et al., 1987; Rijsewijk et al.,
1987). Wnts derive from a 19 member human gene family
encoding 39–44 kDa secreted morphogens with lipid
attached by palmitoylation to effectively concentrate Wnts
near the cell surface (Willert et al., 2003). A heparin
binding domain targets surface heparan sulfate proteogly-
cans, such as syndecan-1, which serve as Wnt coreceptors
(Alexander et al., 2000). Fz receptors bear many similar-
ities to G protein coupled receptors at both structural and
functional levels and signal either through calcium in a
pertussis toxin-sensitive manner or via h-catenin (Wang
and Malbon, 2003). Both Wnt pathways are mediated by
the cytoplasmic phosphoprotein Dishevelled (Dsh). In the
calcium pathway, Dsh is placed downstream of a pertussis
toxin-sensitive step in which Gao or Gaq (or Gat) of the
Gahg protein complex binds the Fz cytoplasmic domain
and exchanges GDP for GTP (Liu et al., 2001). Dsh is
upstream of steps involving the sequential activation of
protein kinase C (PKC), Ca2+/calmodulin-dependent pro-
tein kinase II (Sheldahl et al., 2003), and calcineurin
(Wang and Malbon, 2003). Adding to the Wnt-1/5a sig-
naling arsenal is transactivation of ErbB1 (Civenni et al.,
2003), as noted previously. The h-catenin (‘Wnt canoni-
cal’) pathway is triggered by Wnt ligation of Fz in the
presence of transmembrane low-density lipoprotein-
receptor-related proteins-5 or -6 (‘LRP5/6’), without which
little or no Wnt signaling is observed (Schweizer and
Varmus, 2003). Indeed, binding of LRP6 by the Wnt
antagonist Dickkopf-1 inhibits Wnt signaling (Bafico et
al., 2001). Fz and LRP6 are united by the h-catenin
binding or scaffolding protein axin, which targets the
cytoplasmic domain of LRP directly, and Fz indirectly
via Dishevelled (Dsh; Schweizer and Varmus, 2003).
Activated Dsh inhibits h-catenin phosphorylation by gly-
cogen synthase kinase (GSK)3-h, thereby stabilizing h-
catenin. Rising cytoplasmic levels of h-catenin lead to
nuclear entry, aggregation with transcription factor LEF-
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differentially expressed in exocrine glands (Wnts 2, 4,
5a, 5b, 6, 7b, 10b, and 16a; Fear et al., 2000; Gavin and
McMahon, 1992; Lane and Leder, 1997; Weber-Hall et al.,
1994; Unigene), but only Wnt-4 is currently known to be
indispensable for exocrine morphogenesis as studied by
gene ablation (Brisken et al., 2000).
Wnt-4 is expressed during late ductal branching by
epithelial cells (Fig. 3) of the mammary gland (Weber-Hall
et al., 1994) and has also been detected in pancreas
(GeneCard). Wnt-4 is highly conserved between human
and mouse or rat (Table 3), and accordingly Wnt-4/ mice
are perinatal lethal. Transplantation of midgestational Wnt-
4/ mammary epithelia into mesenchyme of wild-type
pregnant mice revealed a marked deficiency in ductal
branching that became less obvious with time, suggesting
compensation by the late appearing (Weber-Hall et al.,
1994) Wnts-5a, -5b, and -6. No differences were noted
when transplanted into mesenchyme of virgin mice, sug-
gesting that Wnt-4 responsiveness was pregnancy depen-
dent (Brisken et al., 2000). Indeed, Wnt-4 expression is
triggered by progesterone, unlike stromally expressed Wnts-
5a and -6, and epithelial Wnt-5b (Brisken et al., 2000). Wnt-
4 signals via h-catenin to the transcription factor LEF-1, in
keeping with the requirement of h-catenin for alveolar
formation, as studied using WAP and MMTV promoter
constructs predominantly active during this time (Tepera et
al., 2003; noted earlier in cadherin section), and observation
of LEF-1/ mice that lack mammary glands and die at
birth (van Genderen et al., 1994). Moreover, Wnt-4 over-
expression in mammary epithelial cells promotes ductal
branching (Bradbury et al., 1995). The same has also been
observed for Wnt-1 overexpression (Brisken et al., 2000) in
a possibly less phenotypically normal (Bradbury et al.,
1995) or hyperplastic (Tsukamoto et al., 1988) manner
dependent presumably on dose, in keeping with a role for
nonnative Wnt-1 expression in tumorigenesis.Perspectives
A remarkable collection of morphogenic cell adhesion
molecules, growth factors, and their receptors have emerged
from the increasing number of mouse gene knockout,
dominant-negative, and antisense models. That each is
essential, even though overlapping in expression, speaks
to the manner by which multiple gene products drive
glandular organogenesis at any given point of time. Possibly
cells and/or cell groups in developing tissues behave like
dynamic microprocessors (Wiley et al., 2003) capable of
integrating common and diverse signaling networks into a
rationale organogenic outcome. Future study will require a
systematic assimilation of molecular data, broadly collected
in time and space. Such analyses should be inclusive of
gland-restricted factors (i.e., the lacrimal gland prosecretory
mitogen lacritin; Sanghi et al., 2001) that may trigger keydevelopmental pathways and cellular functions. Optimally,
one could seek to apply real time imaging to the documen-
tation of green fluorescent protein-tagged glandular mor-
phogenesis in living mice, as would be practically possible
with the subcutaneous lacrimal, mammary, and salivary
glands. If genes were systematically ablated in a conditional,
time-controlled manner, and if high resolution imaging was
utilized, the gathered data would be very informative and
potentially applicable to computational modeling. Integra-
tion of the interweaving influences of cell adhesion factors,
growth factors, transcription factors, and hormones during
the course of exocrine glandular morphogenesis is a tall
order, but one which holds considerable promise.Acknowledgments
Gene knockout searches were facilitated by the Bio-
MedNet Mouse Knockout and Mutation Database (http://
www.research.bmn.com/mkmd/search/). This work was
supported by NIH grant EY13143 (GWL).References
Affolter, M., et al., 2003. Tube or not tube: remodeling epithelial tissues by
branching morphogenesis. Dev. Cell 4, 11–18.
Ahmed, F., et al., 2002. GFP expression in the mammary gland for imag-
ing of mammary tumor cells in transgenic mice. Cancer Res. 62,
7166–7169.
Alexander, C.M., et al., 2000. Syndecan-1 is required for Wnt-1-induced
mammary tumorigenesis in mice. Nat. Genet. 25, 329–332.
Alexander, C.M., et al., 2001. Stromelysin-1 regulates adipogenesis during
mammary gland involution. J. Cell Biol. 152, 693–703.
Ahlgren, U., et al., 1997. Independent requirement for ISL1 in formation of
pancreatic mesenchyme and islet cells. Nature 385, 257–260.
Allen, B.L., Filla, M.S., Rapraeger, A.C., 2001. Role of heparan sulfate as a
tissue-specific regulator of FGF-4 and FGF receptor recognition. J. Cell
Biol. 155, 845–858.
Bafico, A., et al., 2001. Novel mechanism of Wnt signalling inhibition
mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol.
3, 683–686.
Baker, A.H., Edwards, D.R., Murphy, G., 2002. Metalloproteinase inhib-
itors: biological actions and therapeutic opportunities. J. Cell. Sci. 115,
3719–3727.
Bakre, M.M., et al., 2002. Parathyroid hormone-related peptide is a natu-
rally occurring, protein kinase A-dependent angiogenesis inhibitor. Nat.
Med. 8, 995–1003.
Bamber, B.A., et al., 1994. Leukemia inhibitory factor induces neurotrans-
mitter switching in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91,
7839–7843.
Barcellos-Hoff, M.H., Ewan, K.B., 2000. Transforming growth factor-beta
and breast cancer: mammary gland development. Breast Cancer Res. 2,
92–99.
Bhanot, P., et al., 1996. A new member of the frizzled family from Dro-
sophila functions as a Wingless receptor. Nature 382, 225–230.
Bhushan, A., et al., 2001. Fgf10 is essential for maintaining the prolifera-
tive capacity of epithelial progenitor cells during early pancreatic or-
ganogenesis. Development 128, 5109–5117.
Birchmeier, C., Gherardi, E., 1998. Developmental roles of HGF/SF and its
receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8, 404–410.
Bissell, M.J., Barcellos-Hoff, M.H., 1987. The influence of extracellular
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–2218matrix on gene expression: is structure the message? J. Cell. Sci. Suppl.
8, 327–343.
Bissell, M.J., Hall, H.G., Parry, G., 1982. How does the extracellular matrix
direct gene expression? J. Theor. Biol. 99, 31–68.
Boivin, G.P., et al., 1995. Onset and progression of pathological lesions in
transforming growth factor-beta 1-deficient mice. Am. J. Pathol. 146,
276–288.
Bonnette, S.G., Hadsell, D.L., 2001. Targeted disruption of the IGF-I re-
ceptor gene decreases cellular proliferation in mammary terminal end
buds. Endocrinology 142, 4937–4945.
Bottinger, E.P., et al., 1997. Expression of a dominant-negative mutant
TGF-beta type II receptor in transgenic mice reveals essential roles
for TGF-beta in regulation of growth and differentiation in the exocrine
pancreas. EMBO J. 16, 2621–2633.
Boussadia, O., et al., 2002. E-cadherin is a survival factor for the lactating
mouse mammary gland. Mech. Dev. 115, 53–62.
Boyle, W.J., Simonet, W.S., Lacey, D.L., 2003. Osteoclast differentiation
and activation. Nature 423, 337–342.
Bradbury, J.M., et al., 1995. Wnt-4 expression induces a pregnancy-like
growth pattern in reconstituted mammary glands in virgin mice. Dev.
Biol. 170, 553–563.
Brantley, D.M., et al., 2001. Nuclear factor-kappaB (NF-kappaB) regulates
proliferation and branching in mouse mammary epithelium. Mol. Biol.
Cell 12, 1445–1455.
Brisken, C., et al., 2000. Essential function of Wnt-4 in mammary gland
development downstream of progesterone signaling. Genes Dev. 14,
650–654.
Cabrera, C.V., et al., 1987. Phenocopies induced with antisense RNA iden-
tify the wingless gene. Cell 50, 659–663.
Cao, Y., et al., 2001. IKKalpha provides an essential link between RANK
signaling and cyclin D1 expression during mammary gland develop-
ment. Cell 107, 763–775.
Carraway III, K.L., et al., 1999. An intramembrane modulator of the ErbB2
receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol.
Chem. 274, 5263–5266.
Castle, A.M., Huang, A.Y., Castle, J.D., 2002. The minor regulated path-
way, a rapid component of salivary secretion, may provide docking/
fusion sites for granule exocytosis at the apical surface of acinar cells.
J. Cell. Sci. 115, 2963–2973.
Celli, G., et al., 1998. Soluble dominant-negative receptor uncovers essen-
tial roles for fibroblast growth factors in multi-organ induction and
patterning. EMBO J. 17, 1642–1655.
Chapman, S.C., et al., 2002. Properties of inhibin binding to betaglycan,
InhBP/p120 and the activin type II receptors. Mol. Cell. Endocrinol.
196, 79–93.
Chen, J., et al., 2002. The alpha(2) integrin subunit-deficient mouse: a
multifaceted phenotype including defects of branching morphogenesis
and hemostasis. Am. J. Pathol. 161, 337–344.
Chiarugi, P., et al., 2003. Reactive oxygen species as essential mediators of
cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is
required for cell adhesion. J. Cell Biol. 161, 933–944.
Chuang, P.T., McMahon, A.P., 1999. Vertebrate Hedgehog signalling
modulated by induction of a Hedgehog-binding protein. Nature 397,
617–621.
Cichy, J., Pure, E., 2003. The liberation of CD44. J. Cell Biol. 161,
839–843.
Civenni, G., Holbro, T., Hynes, N.E., 2003. Wnt1 and Wnt5a induce cyclin
D1 expression through ErbB1 transactivation in HC11 mammary epi-
thelial cells. EMBO Rep. 4, 166–171.
Cohen, S., 1962. Isolation of a mouse submaxillary gland protein ac-
celerating incisor eruption and eyelid opening in the new-born animal.
J. Biol. Chem. 237, 1555–1562.
Colognato, H., Yurchenco, P.D., 2000. Form and function: the laminin
family of heterotrimers. Dev. Dyn. 218, 213–234.
Crisera, C.A., et al., 2000. Transforming growth factor-beta 1 in the devel-
oping mouse pancreas: a potential regulator of exocrine differentiation.
Differentiation 65, 255–259.Curat, C.A., et al., 2001. Mapping of epitopes in discoidin domain receptor
1 critical for collagen binding. J. Biol. Chem. 276, 45952–45958.
Davenport, T.G., et al., 2003. Mammary gland, limb and yolk sac defects in
mice lacking Tbx3, the gene mutated in human ulnar mammary syn-
drome. Development 130, 2263–2273.
De Arcangelis, A., et al., 1999. Synergistic activities of alpha3 and alpha6
integrins are required during apical ectodermal ridge formation and
organogenesis in the mouse. Development 126, 3957–3968.
De Crescenzo, G., et al., 2001. Real-time monitoring of the interactions of
transforming growth factor-beta (TGF-beta ) isoforms with latency-
associated protein and the ectodomains of the TGF-beta type II and III
receptors reveals different kinetic models and stoichiometries of binding.
J. Biol. Chem. 276, 29632–29643.
De Moerlooze, L., et al., 2000. An important role for the IIIb isoform of
fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial
signalling during mouse organogenesis. Development 127, 483–492.
Dejmek, J., et al., 2003. Wnt-5a and G-protein signaling are required for
collagen-induced DDR1 receptor activation and normal mammary cell
adhesion. Int. J. Cancer 103, 344–351.
Delmas, V., et al., 1999. Expression of the cytoplasmic domain of E-
cadherin induces precocious mammary epithelial alveolar formation
and affects cell polarity and cell-matrix integrity. Dev. Biol. 216,
491–506.
Dichmann, D.S., et al., 2003. Expression and misexpression of members of
the FGF and TGFbeta families of growth factors in the developing
mouse pancreas. Dev. Dyn. 226, 663–674.
Dillon, R., Gadgil, C., Othmer, H.G., 2003. Short- and long-range effects of
sonic hedgehog in limb development. Proc. Natl. Acad. Sci. U.S.A.
100, 10152–10157.
Dunbar, M.E., et al., 1999. Parathyroid hormone-related protein signaling is
necessary for sexual dimorphism during embryonic mammary develop-
ment. Development 126, 3485–3493.
Edlund, H., 2002. Pancreatic organogenesis—Developmental mechanisms
and implications for therapy. Nat. Rev. Genet. 3, 524–532.
Edwards, D.R., et al., 1987. Transforming growth factor beta modulates the
expression of collagenase and metalloproteinase inhibitor. EMBO J. 6,
1899–1904.
Esni, F., et al., 2001. Dorsal pancreas agenesis in N-cadherin-deficient
mice. Dev. Biol. 238, 202–212.
Esparza-Lopez, J., et al., 2001. Ligand binding and functional properties of
betaglycan, a co-receptor of the transforming growth factor-beta super-
family. Specialized binding regions for transforming growth factor-beta
and inhibin A. J. Biol. Chem. 276, 14588–14596.
Etienne-Manneville, S., Hall, A., 2003. Cdc42 regulates GSK-3beta and
adenomatous polyposis coli to control cell polarity. Nature 421,
753–756.
Faraldo, M.M., et al., 2001. Growth defects induced by perturbation of
beta1-integrin function in the mammary gland epithelium result from
a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep.
2, 431–437.
Fata, J.E., et al., 1999. Timp-1 is important for epithelial proliferation and
branching morphogenesis during mouse mammary development. Dev.
Biol. 211, 238–254.
Fata, J.E., et al., 2000. The osteoclast differentiation factor osteoprotegerin-
ligand is essential for mammary gland development. Cell 103, 41–50.
Fata, J.E., et al., 2001. Accelerated apoptosis in the Timp-3-deficient mam-
mary gland. J. Clin. Invest. 108, 831–841.
Fear, M.W., et al., 2000. Wnt-16a, a novel Wnt-16 isoform, which shows
differential expression in adult human tissues. Biochem. Biophys. Res.
Commun. 278, 814–820.
Firth, S.M., Baxter, R.C., 2002. Cellular actions of the insulin-like growth
factor binding proteins. Endocr. Rev. 23, 824–854.
Foley, J., et al., 2001. Parathyroid hormone-related protein maintains mam-
mary epithelial fate and triggers nipple skin differentiation during em-
bryonic breast development. Development 128, 513–525.
Gallego, M.I., et al., 2002. Differential requirements for shh in mammary
tissue and hair follicle morphogenesis. Dev. Biol. 249, 131–139.
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–22 19Gallet, A., et al., 2003. Cholesterol modification of hedgehog is required
for trafficking and movement, revealing an asymmetric cellular re-
sponse to hedgehog. Dev. Cell 4, 191–204.
Gavin, B.J., McMahon, A.P., 1992. Differential regulation of the Wnt gene
family during pregnancy and lactation suggests a role in postnatal de-
velopment of the mammary gland. Mol. Cell. Biol. 241, 8–23.
Golosow, N., Grobstein, C., 1962. Epitheliomesenchymal interaction in
pancreatic morphogenesis. Dev. Biol. 4, 242–255.
Goodrich, L.V., et al., 1997. Altered neural cell fates and medulloblastoma
in mouse patched mutants. Science 277, 1109–1113.
Gorska, A.E., et al., 1998. Dominant-negative interference of the trans-
forming growth factor beta type II receptor in mammary gland epithe-
lium results in alveolar hyperplasia and differentiation in virgin mice.
Cell Growth Differ. 9, 229–238.
Gospodarowicz, D., 1974. Localisation of a fibroblast growth factor and its
effect alone and with hydrocortisone on 3T3 cell growth. Nature 249,
123–127.
Gouon-Evans, V., Rothenberg, M.E., Pollard, J.W., 2000. Postnatal
mammary gland development requires macrophages and eosinophils.
Development 127, 2269–2282.
Govindarajan, V., et al., 2000. Endogenous and ectopic gland induction by
FGF-10. Dev. Biol. 225, 188–200.
Gritli-Linde, A., et al., 2001. The whereabouts of a morphogen: direct
evidence for short- and graded long-range activity of hedgehog signal-
ing peptides. Dev. Biol. 236, 364–386.
Gschwind, A., et al., 2003. TACE cleavage of proamphiregulin regulates
GPCR-induced proliferation and motility of cancer cells. EMBO J. 22,
2411–2421.
Gu, G., Brown, J.R., Melton, D.A., 2003. Direct lineage tracing reveals the
ontogeny of pancreatic cell fates during mouse embryogenesis. Mech.
Dev. 120, 35–43.
Gumbiner, B.M., 1996. Cell adhesion: the molecular basis of tissue archi-
tecture and morphogenesis. Cell 84, 345–357.
Gumbiner, B., Simons, K., 1986. A functional assay for proteins involved
in establishing an epithelial occluding barrier: identification of a uvo-
morulin-like polypeptide. J. Cell Biol. 102, 457–468.
Hajihosseini, M.K., et al., 2001. A splicing switch and gain-of-function
mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-
like phenotypes. Proc. Natl. Acad. Sci U.S.A. 98, 3855–3860.
Harris, R.C., Chung, E., Coffey, R.J., 2003. EGF receptor ligands. Exp.
Cell Res. 284, 2–13.
Hathaway, H.J., Shur, B.D., 1996. Mammary gland morphogenesis is
inhibited in transgenic mice that overexpress cell surface beta1,4-gal-
actosyltransferase. Development 122, 2859–2872.
Hebrok, M., Kim, S.K., Melton, D.A., 1998. Notochord repression of
endodermal sonic hedgehog permits pancreas development. Genes
Dev. 12, 1705–1713.
Hebrok, M., et al., 2000. Regulation of pancreas development by hedgehog
signaling. Development 127, 4905–4913.
Hedgecock, E.M., Culotti, J.G., Hall, D.H., 1990. The unc-5, unc-6,
and unc-40 genes guide circumferential migrations of pioneer axons
and mesodermal cells on the epidermis in C. elegans. Neuron 4,
61–85.
Hendriks, B.S., et al., 2003. Quantitative analysis of HER2-mediated
effects on HER2 and EGFR endocytosis: distribution of homo- and
hetero-dimers depends on relative HER2 levels. J. Biol. Chem. 278,
23343–23351.
Hennighausen, L., Robinson, G.W., 1998. Think globally, act locally: the
making of a mouse mammary gland. Genes Dev. 12, 449–455.
Hoffman, M.P., et al., 2002. Gene expression profiles of mouse subman-
dibular gland development: FGFR1 regulates branching morphogenesis
in vitro through BMP- and FGF-dependent mechanisms. Development
129, 5767–5778.
Hogan, B.L., 1999. Morphogenesis. Cell 96, 225–233.
Hogan, B.L., Kolodziej, P.A., 2002. Organogenesis: molecular mechanisms
of tubulogenesis. Nat. Rev. Genet. 3, 513–523.
Hyafil, F., Babinet, C., Jacob, F., 1981. Cell-cell interactions in earlyembryogenesis: a molecular approach to the role of calcium. Cell 26,
447–454.
Hynes, R.O., 2002. Integrins: bidirectional, allosteric signaling machines.
Cell 110, 673–687.
Imbert, A., et al., 2001. Delta N89 beta-catenin induces precocious devel-
opment, differentiation, and neoplasia in mammary gland. J. Cell Biol.
153, 555–568.
Ito, S., et al., 2002. Crystal structure of the extracellular domain of mouse
RANK ligand at 2.2-A resolution. J. Biol. Chem. 277, 6631–6636.
Jackson, L.F., et al., 2003. Defective valvulogenesis in HB-EGF and
TACE-null mice is associated with aberrant BMP signaling. EMBO J.
22, 2704–2716.
Jaskoll, T., Melnick, M., 1999. Submandibular gland morphogenesis:
stage-specific expression of TGF-alpha/EGF, IGF, TGF-beta, TNF,
and IL-6 signal transduction in normal embryonic mice and the pheno-
typic effects of TGF-beta2, TGF-beta3, and EGF-r null mutations. Anat.
Rec. 256, 252–268.
Jaskoll, T., et al., 2002. Embryonic submandibular gland morphogene-
sis: stage-specific protein localization of FGFs, BMPs, Pax6 and
Pax9 in normal mice and abnormal SMG phenotypes in FgfR2-
IIIc(+/Delta), BMP7(/) and Pax6(/) mice. Cells Tissues
Organs 170, 83–98.
Jaskoll, T., et al., 2004. Sonic hedgehog signaling plays an essential role
during embryonic salivary gland epithelial branching morphogenesis.
Dev. Dyn. 229, 722–732.
Jeruss, J.S., Santiago, J.Y., Woodruff, T.K., 2003. Localization of activin
and inhibin subunits, receptors and SMADs in the mouse mammary
gland. Mol. Cell. Endocrinol. 203, 185–196.
Jhappan, C., et al., 1993. Targeting expression of a transforming growth
factor beta 1 transgene to the pregnant mammary gland inhibits alveolar
development and lactation. EMBO J. 12, 1835–1845.
Jones, F.E., Stern, D.F., 1999. Expression of dominant-negative ErbB2 in
the mammary gland of transgenic mice reveals a role in lobuloalveolar
development and lactation. Oncogene 18, 3481–3490.
Jones, F.E., et al., 1999. ErbB4 signaling in the mammary gland is required
for lobuloalveolar development and Stat5 activation during lactation.
J. Cell Biol. 147, 77–88.
Jonsson, M., Andersson, T., 2001. Repression of Wnt-5a impairs DDR1
phosphorylation and modifies adhesion and migration of mammary
cells. J. Cell. Sci. 114, 2043–2053.
Joseph, H., et al., 1999. Overexpression of a kinase-deficient transforming
growth factor-beta type II receptor in mouse mammary stroma results in
increased epithelial branching. Mol. Biol Cell 10, 1221–1234.
Kadoya, Y., et al., 1995. Antibodies against domain E3 of laminin-1 and
integrin alpha 6 subunit perturb branching epithelial morphogenesis
of submandibular gland, but by different modes. J. Cell Biol. 129,
521–534.
Kanno, H., et al., 2003. Cholinergic agonists transactivate EGFR and stim-
ulate MAPK to induce goblet cell secretion. Am. J. Physiol., Cell
Physiol. 284, C988–C998.
Kawahira, H., et al., 2003. Combined activities of hedgehog signaling inhib-
itors regulate pancreas development. Development 30, 4871–4879.
Kawakami, T., et al., 2002. Mouse dispatched mutants fail to distribute
hedgehog proteins and are defective in hedgehog signaling. Develop-
ment 129, 5753–5765.
Keely, P.J., Wu, J.E., Santoro, S.A., 1995. The spatial and temporal ex-
pression of the alpha 2 beta 1 integrin and its ligands, collagen I,
collagen IV, and laminin, suggest important roles in mouse mammary
morphogenesis. Differentiation 59, 1–13.
Khosla, S., 2001. Minireview: the OPG/RANKL/RANK system. Endocri-
nology 142, 5050–5055.
Kido, Y., et al., 2002. Effects of mutations in the insulin-like growth factor
signaling system on embryonic pancreas development and beta-cell
compensation to insulin resistance. J. Biol. Chem. 277, 36740–36747.
Kim, S.K., 2000. Activin receptor patterning of foregut organogenesis.
Genes Dev. 14, 1866–1871.
Kim, H.J., et al., 2002. Osteoprotegerin ligand induces beta-casein gene
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–2220expression through the transcription factor CCAAT/enhancer-binding
protein beta. J. Biol. Chem. 277, 5339–5344.
Klinowska, T.C., et al., 2001. Epithelial development and differentiation in
the mammary gland is not dependent on alpha 3 or alpha 6 integrin
subunits. Dev. Biol. 233, 449–467.
Knox, S., et al., 2002. Not all perlecans are created equal: interactions with
fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem. 277,
14657–14665.
Kratochwil, K., 1971. In vitro analysis of the hormonal basis for the sexual
dimorphism in the embryonic development of the mouse mammary
gland. J. Embryol. Exp. Morphol. 25, 141–153.
Kresse, H., Schonherr, E., 2001. Proteoglycans of the extracellular matrix
and growth control. J. Cell. Physiol. 189, 266–274.
Kritikou, E.A., et al., 2003. A dual, non-redundant, role for LIF as a
regulator of development and STAT3-mediated cell death in mammary
gland. Development 130, 3459–3468.
Kulkarni, A.B., et al., 1993. Transforming growth factor beta 1 null muta-
tion in mice causes excessive inflammatory response and early death.
Proc. Natl. Acad. Sci. U.S.A. 90, 770–774.
Kulkarni, A.B., et al., 1995. Transforming growth factor-beta 1 null mice. An
animal model for inflammatory disorders. Am. J. Pathol. 146, 264–275.
Lane, T.F., Leder, P., 1997. Wnt-10b directs hypermorphic development
and transformation in mammary glands of male and female mice. On-
cogene 15, 2133–2144.
Larue, L., et al., 1994. E-cadherin null mutant embryos fail to form
a trophectoderm epithelium. Proc. Natl. Acad. Sci. U.S.A. 91,
8263–8267.
Laurie, G.W., Leblond, C.P., Martin, G.R., 1982. Localization of type IV
collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the
basal lamina of basement membranes. J. Cell Biol. 95, 340–344.
Laurie, G.W., et al., 1986. Localization of binding sites for laminin, hep-
aran sulfate proteoglycan and fibronectin on basement membrane (type
IV) collagen. J. Mol. Biol. 189, 205–216.
Lecuit, T., Pilot, F., 2003. Developmental control of cell morphogenesis: a
focus on membrane growth. Nat. Cell Biol. 5, 103–108.
Lee, P.S., et al., 2003. Sumoylation of Smad4, the common Smad mediator
of transforming growth factor-beta family signaling. J. Biol. Chem. 278,
27853–27863.
Lee, Y.J., Streuli, C.H., 1999. Extracellular matrix selectively modulates
the response of mammary epithelial cells to different soluble signaling
ligands. J. Biol. Chem. 274, 22401–22408.
Lewis, M.T., et al., 1999. Defects in mouse mammary gland development
caused by conditional haploinsufficiency of Patched-1. Development
126, 5181–5193.
Lewis, K.A., et al., 2000. Betaglycan binds inhibin and can mediate func-
tional antagonism of activin signalling. Nature 404, 411–414.
Lewis, M.T., 2001. The Gli2 transcription factor is required for normal
mouse mammary gland development. Dev. Biol. 238, 133–144.
Li, L., et al., 2002. The breast proto-oncogene, HRGalpha regulates epi-
thelial proliferation and lobuloalveolar development in the mouse mam-
mary gland. Oncogene 21, 4900–4907.
Liu, X., et al., 1997. Stat5a is mandatory for adult mammary gland devel-
opment and lactogenesis. Genes Dev. 11, 179–186.
Liu, T., et al., 2001. G protein signaling from activated rat frizzled-1 to the
beta-catenin-Lef-Tcf pathway. Science 292, 1718–1722.
Long, W., et al., 2003. Impaired differentiation and lactational failure of
Erbb4-deficient mammary glands identify ERBB4 as an obligate medi-
ator of STAT5. Development 130, 5257–5268.
Luetteke, N.C., et al., 1999. Targeted inactivation of the EGF and amphir-
egulin genes reveals distinct roles for EGF receptor ligands in mouse
mammary gland development. Development 126, 2739–2750.
Luo, B.H., Springer, T.A., Takagi, J., 2003. High affinity ligand binding
by integrins does not involve head separation. J. Biol. Chem. 278,
17185–17189.
Mailleux, A.A., et al., 2002. Role of FGF10/FGFR2b signaling during
mammary gland development in the mouse embryo. Development
129, 53–60.Makarenkova, H.P., et al., 2000. FGF10 is an inducer and Pax6 a com-
petence factor for lacrimal gland development. Development 127,
2563–2572.
Maldonado, T.S., et al., 2000. Ontogeny of activin B and follistatin in
developing embryonic mouse pancreas: implications for lineage selec-
tion. J. Gastrointest. Surg. 4, 269–275.
Massova, I., et al., 1998. Matrix metalloproteinases: structures, evolution,
and diversification. FASEB J. 12, 1075–1095.
Matter, M.L., Laurie, G.W., 1994. A novel laminin E8 cell adhesion site
required for lung alveolar formation in vitro. J. Cell Biol. 124,
1083–1090.
Medley, Q.G., et al., 2003. Signaling between focal adhesion kinase and
trio. J. Biol. Chem. 278, 13265–13270.
Menko, A.S., et al., 2001. Loss of alpha3beta1 integrin function results in
an altered differentiation program in the mouse submandibular gland.
Dev. Dyn. 220, 337–349.
Mercurio, A.M., 2002. Lessons from the alpha2 integrin knockout mouse.
Am. J. Pathol. 161, 3–6.
Michno, K., et al., 2003. Shh expression is required for embryonic hair
follicle but not mammary gland development. Dev. Biol. 264, 153–165.
Miettinen, P.J., et al., 1995. Epithelial immaturity and multiorgan failure in
mice lacking epidermal growth factor receptor. Nature 376, 337–341.
Miralles, F., et al., 1999. Signaling through fibroblast growth factor recep-
tor 2b plays a key role in the development of the exocrine pancreas.
Proc. Natl. Acad. Sci. U.S.A. 96, 6267–6272.
Mohan, S., Thompson, G.R., Amaar, Y.G., Hathaway, G., Tschesche, H.,
Baylink, D.J., 2002. ADAM-9 is an insulin-like growth factor binding
protein-5 protease produced and secreted by human osteoblasts. Bio-
chem. 41, 15394–15403.
Moseley, J.M., et al., 1987. Parathyroid hormone-related protein purified
from a human lung cancer cell line. Proc. Natl. Acad. Sci. U.S.A. 84,
5048–5052.
Muller, T., et al., 1999. Phosphorylation and free pool of beta-catenin are
regulated by tyrosine kinases and tyrosine phosphatases during epithe-
lial cell migration. J. Biol. Chem. 274, 10173–10183.
Murdoch, A.D., et al., 1992. Primary structure of the human heparan sulfate
proteoglycan from basement membrane (HSPG2/perlecan). A chimeric
molecule with multiple domains homologous to the low density lipo-
protein receptor, laminin, neural cell adhesion molecules, and epidermal
growth factor. J. Biol. Chem. 267, 8544–8557.
Nakagawa, N., et al., 1998. RANK is the essential signaling receptor for
osteoclast differentiation factor in osteoclastogenesis. Biochem. Bio-
phys. Res. Commun. 253, 395–400. Nature 423, 448–452.
Nemir, M., et al., 2000. Targeted inhibition of osteopontin expression in the
mammary gland causes abnormal morphogenesis and lactation deficien-
cy. J. Biol. Chem. 275, 969–976.
Noonan, D.M., et al., 1991. The complete sequence of perlecan, a basement
membrane heparan sulfate proteoglycan, reveals extensive similarity
with laminin A chain, low density lipoprotein-receptor, and the neural
cell adhesion molecule. J. Biol. Chem. 266, 22939–22947.
Noren, N.K., Arthur, W.T., Burridge, K., 2003. Cadherin engagement
inhibits RhoA via p190RhoGAP. J. Biol. Chem. 278, 13615–13618.
Nusse, R., Varmus, H.E., 1982. Many tumors induced by the mouse mam-
mary tumor virus contain a provirus integrated in the same region of the
host genome. Cell 31, 99–109.
Nusslein-Volhard, C., Wieschaus, E., 1980. Mutations affecting segment
number and polarity in Drosophila. Nature 287, 795–801.
Ogou, S.I., Yoshida-Noro, C., Takeichi, M., 1983. Calcium-dependent
cell –cell adhesion molecules common to hepatocytes and teratocarci-
noma stem cells. J. Cell Biol. 97, 944–948.
Ohuchi, H., et al., 2000. FGF10 acts as a major ligand for FGF receptor 2
IIIb in mouse multi-organ development. Biochem. Biophys. Res. Com-
mun. 277, 643–649.
Ongusaha, P.P., et al., 2003. p53 induction and activation of DDR1 kinase
counteract p53-mediated apoptosis and influence p53 regulation
through a positive feedback loop. EMBO J. 22, 1289–12301.
Ostrovsky, O., et al., 2002. Differential effects of heparin saccharides on the
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–22 21formation of specific fibroblast growth factor (FGF) and FGF receptor
complexes. J. Biol. Chem. 277, 2444–2453.
Ozkaynak, E., et al., 1990. OP-1 cDNA encodes an osteogenic protein in
the TGF-beta family. EMBO J. 9, 2085–2093.
Park, Y., et al., 2003. Drosophila perlecan modulates FGF and hedge-
hog signals to activate neural stem cell division. Dev. Biol. 253,
247–257.
Parsons, J.T., 2003. Focal adhesion kinase: the first ten years. J. Cell. Sci.
116, 1409–1416.
Payet, L.D., et al., 2003. Amino- and carboxyl-terminal fragments of in-
sulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs
with high affinity and inhibit IGF receptor interactions. Endocrinology
144, 2797–2806.
Pepinsky, R.B., et al., 1998. Identification of a palmitic acid-modified form
of human sonic hedgehog. J. Biol. Chem. 273, 14037–14045.
Perez-Moreno, M., Jamora, C., Fuchs, E., 2003. Sticky business: orches-
trating cellular signals at adherens junctions. Cell 112, 535–548.
Phippard, D.J., et al., 1996. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-
4 during foetal and postnatal mammary gland development. Develop-
ment 122, 2729–2737.
Pierce Jr., D.F., et al., 1993. Inhibition of mammary duct development but
not alveolar outgrowth during pregnancy in transgenic mice expressing
active TGF-beta 1. Genes Dev. 7, 2308–2317.
Pin, C.L., et al., 2001. The bHLH transcription factor Mist1 is required to
maintain exocrine pancreas cell organization and acinar cell identity.
J. Cell Biol. 155, 519–530.
Pollard, J.W., Hennighausen, L., 1994. Colony stimulating factor 1 is re-
quired for mammary gland development during pregnancy. Proc. Natl.
Acad. Sci. U.S.A. 91, 9312–9316.
Porter, J.A., et al., 1996. Hedgehog patterning activity: role of a lipophilic
modification mediated by the carboxy-terminal autoprocessing domain.
Cell 86, 21–34.
Prince, J.M., et al., 2002. Cell-matrix interactions during development
and apoptosis of the mouse mammary gland in vivo. Dev. Dyn. 223,
497–516.
Radice, G.L., et al., 1997a. Precocious mammary gland development in P-
cadherin-deficient mice. J. Cell Biol. 139, 1025–1032.
Radice, G.L., et al., 1997b. Developmental defects in mouse embryos
lacking N-cadherin. Dev. Biol. 181, 64–78.
Ramalho-Santos, M., Melton, D.A., McMahon, A.P., 2000. Hedgehog sig-
nals regulate multiple aspects of gastrointestinal development. Devel-
opment 127, 2763–2772.
Raman, R., et al., 2003. Structural specificity of heparin binding in the
fibroblast growth factor family of proteins. Proc. Natl. Acad. Sci.
U.S.A. 100, 2357–2362.
Ramirez, F., Rifkin, D.B., 2003. Cell signaling events: a view from the
matrix. Matrix Biol. 22, 101–107.
Ramsauer, V.P., et al., 2003. Muc4/sialomucin complex, the intramembrane
ErbB2 ligand, translocates ErbB2 to the apical surface in polarized
epithelial cells. J. Biol. Chem. 278, 30142–30147.
Revest, J.M., et al., 2001. Fibroblast growth factor receptor 2-IIIb acts
upstream of Shh and Fgf4 and is required for limb bud maintenance
but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev. Biol.
231, 47–62.
Riethmacher, D., Brinkmann, V., Birchmeier, C., 1995. A targeted mutation
in the mouse E-cadherin gene results in defective preimplantation de-
velopment. Proc. Natl Acad. Sci. U.S.A. 92, 855–859.
Rijsewijk, F., et al., 1987. The Drosophila homolog of the mouse mammary
oncogene int-1 is identical to the segment polarity gene wingless. Cell
50, 649–657.
Rittling, S.R., Novick, K.E., 1997. Osteopontin expression in mamma-
ry gland development and tumorigenesis. Cell Growth Differ. 8,
1061–1069.
Robinson, G.W., Hennighausen, L., 1997. Inhibins and activins regulate
mammary epithelial cell differentiation through mesenchymal-epithelial
interactions. Development 124, 2701–2708.
Robinson, S.D., Roberts, A.B., Daniel, C.W., 1993. TGF beta suppressescasein synthesis in mouse mammary explants and may play a role in
controlling milk levels during pregnancy. J. Cell Biol. 120, 245–251.
Robinson, G.W., et al., 1998. The C/EBPbeta transcription factor regulates
epithelial cell proliferation and differentiation in the mammary gland.
Genes Dev. 12, 1907–1916.
Ruan, W., Kleinberg, D.L., 1999. Insulin-like growth factor I is essential
for terminal end bud formation and ductal morphogenesis during mam-
mary development. Endocrinology 140, 5075–5081.
Ryan, G.R., et al., 2001. Rescue of the colony-stimulating factor 1 (CSF-
1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1
transgene and identification of sites of local CSF-1 synthesis. Blood
98, 74–84.
Sakai, T., Larsen, M., Yamada, K.M., 2003. Fibronectin requirement in
branching morphogenesis. Nature 423, 876–881.
Salminen, M., et al., 2000. Netrin 1 is required for semicircular canal
formation in the mouse inner ear. Development 127, 13–22.
Sanghi, S., et al., 2001. cDNA and genomic cloning of lacritin, a novel
secretion enhancing factor from the human lacrimal gland. J. Mol. Biol.
310, 127–139.
Schaapveld, R.Q., et al., 1997. Impaired mammary gland development and
function in mice lacking LAR receptor-like tyrosine phosphatase activ-
ity. Dev. Biol. 188, 134–146.
Schenk, S., et al., 2003. Binding to EGF receptor of a laminin-5 EGF-like
fragment liberated during MMP-dependent mammary gland involution.
J. Cell Biol. 161, 197–209.
Schere-Levy, C., et al., 2003. Leukemia inhibitory factor induces apoptosis
of the mammary epithelial cells and participates in mouse mammary
gland involution. Exp. Cell Res. 282, 35–47.
Schluns, K.S., Cook, J.E., Le, P.T., 1997. TGF-beta differentially modu-
lates epidermal growth factor-mediated increases in leukemia-inhibitory
factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells.
J. Immunol. 158, 2704–2712.
Schmeichel, K.L., Bissell, M.J., 2003. Modeling tissue-specific signaling
and organ function in three dimensions. J. Cell. Sci. 116, 2377–2388.
Schneider, A., et al., 2000. Targeted disruption of the Nkx3.1 gene in mice
results in morphogenetic defects of minor salivary glands: parallels to
glandular duct morphogenesis in prostate. Mech. Dev. 95, 163–174.
Schroeder, J.A., Lee, D.C., 1998. Dynamic expression and activation of
ERBB receptors in the developing mouse mammary gland. Cell Growth
Differ. 9, 451–464.
Schwartz, M.A., Ginsberg, M.H., 2002. Networks and crosstalk: integrin
signalling spreads. Nat. Cell Biol. 4, E65–E68.
Schweizer, L., Varmus, H., 2003. Wnt/Wingless signaling through beta-
catenin requires the function of both LRP/Arrow and frizzled classes of
receptors. BMC Cell Biol. 4, 4.
Seagroves, T.N., et al., 1998. C/EBPbeta, but not C/EBPalpha, is essen-
tial for ductal morphogenesis, lobuloalveolar proliferation, and func-
tional differentiation in the mouse mammary gland. Genes Dev. 12,
1917–1928.
Seagroves, T.N., et al., 2003. HIF1alpha is a critical regulator of secretory
differentiation and activation, but not vascular expansion, in the mouse
mammary gland. Development 130, 1713–1724.
Sebastian, J., et al., 1998. Activation and function of the epidermal growth
factor receptor and ErbB-2 during mammary gland morphogenesis. Cell
Growth Differ. 9, 777–785.
Sheldahl, L.C., et al., 2003. Dishevelled activates Ca2+ flux, PKC, and
CamKII in vertebrate embryos. J. Cell Biol. 161, 769–777.
Shi, Y., Massague, J., 2003. Mechanisms of TGF-signaling from cell mem-
brane to the nucleus. Cell 113, 685–700.
Shiozaki, S., et al., 1999. Impaired differentiation of endocrine and exo-
crine cells of the pancreas in transgenic mouse expressing the truncated
type II activin receptor. Biochim. Biophys. Acta 1450, 1–11.
Sibilia, M., Wagner, E.F., 1995. Strain-dependent epithelial defects in mice
lacking the EGF receptor. Science 269, 234–238.
Silberstein, G.B., et al., 1992. Regulation of mammary morphogenesis:
evidence for extracellular matrix-mediated inhibition of ductal budding
by transforming growth factor-beta 1. Dev. Biol. 152, 354–362.
J. Wang, G.W. Laurie / Developmental Biology 273 (2004) 1–2222Simonet, W.S., et al., 1997. Osteoprotegerin: a novel secreted protein in-
volved in the regulation of bone density. Cell 89, 309–319.
Srinivasan, K., et al., 2003. Netrin-1/Neogenin interaction stabilizes multi-
potent progenitor cap cells during mammary gland morphogenesis. Dev.
Cell 4, 371–382.
Stefana, B., Ray, D.W., Melmed, S., 1996. Leukemia inhibitory factor
induces differentiation of pituitary corticotroph function: an immuno-
neuroendocrine phenotypic switch. Proc. Natl. Acad. Sci. U.S.A. 93,
12502–12506.
Steffgen, K., Dufraux, K., Hathaway, H., 2002. Enhanced branching mor-
phogenesis in mammary glands of mice lacking cell surface beta1,4-
galactosyltransferase. Dev. Biol. 244, 114–133.
Sternlicht, M.D., et al., 1999. The stromal proteinase MMP3/stromelysin-1
promotes mammary carcinogenesis. Cell 98, 137–146.
Suva, L.J., et al., 1987. A parathyroid hormone-related protein implicated
in malignant hypercalcemia: cloning and expression. Science 237,
893–896.
Sympson, C.J., et al., 1994. Targeted expression of stromelysin-1 in mam-
mary gland provides evidence for a role of proteinases in branching
morphogenesis and the requirement for an intact basement membrane
for tissue-specific gene expression. J. Cell Biol. 125, 681–693.
Takeichi, M., 1977. Functional correlation between cell adhesive properties
and some cell surface proteins. J. Cell Biol. 75, 464–474.
Tepera, S.B., McCrea, P.D., Rosen, J.M., 2003. A beta-catenin survival
signal is required for normal lobular development in the mammary
gland. J. Cell. Sci. 116, 1137–1149.
Terpe, H.J., et al., 1994. Alpha 6 integrin distribution in human embryonic
and adult tissues. Histochemistry 101, 41–49.
Tessier-Lavigne, M., et al., 1988. Chemotropic guidance of developing
axons in the mammalian central nervous system. Nature 336, 775–778.
Thibert, C., et al., 2003. Inhibition of neuroepithelial patched-induced ap-
optosis by sonic hedgehog. Science 301, 843–846.
Threadgill, D.W., et al., 1995. Targeted disruption of mouse EGF recep-
tor: effect of genetic background on mutant phenotype. Science 269,
230–234.
Tsukamoto, A.S., et al., 1988. Expression of the int-1 gene in transgenic
mice is associated with mammary gland hyperplasia and adenocarcino-
mas in male and female mice. Cell 55, 619–625.
Van Der Zee, C.E., et al., 2003. Delayed peripheral nerve regeneration and
central nervous system collateral sprouting in leucocyte common anti-
gen-related protein tyrosine phosphatase-deficient mice. Eur. J. Neuro-
sci. 17, 991–1005.
van Genderen, C., et al., 1994. Development of several organs that require
inductive epithelial-mesenchymal interactions is impaired in LEF-1-de-
ficient mice. Genes Dev. 8, 2691–2703.
Van Nguyen, A., Pollard, J.W., 2002. Colony stimulating factor-1 is re-
quired to recruit macrophages into the mammary gland to facilitate
mammary ductal outgrowth. Dev. Biol. 247, 11–25.
Vinson, C.R., Conover, S., Adler, P.N., 1989. A Drosophila tissue polarity
locus encodes a protein containing seven potential transmembrane
domains. Nature 338, 263–264.
Vogel, W., et al., 2000. Discoidin domain receptor 1 is activated indepen-
dently of h1 integrin. J. Biol. Chem. 275, 5779–5784.
Vogel, W.F., et al., 2001. Discoidin domain receptor 1 tyrosine kinase has
an essential role in mammary gland development. Mol. Cell. Biol. 21,
2906–2917.
Wang, H.Y., Malbon, C.C., 2003. Wnt signaling, Ca2+, and cyclic GMP:
visualizing Frizzled functions. Science 300, 1529–1530.Wang, Z., Juttermann, R., Soloway, P.D., 2000. TIMP-2 is required for
efficient activation of proMMP-2 in vivo. J. Biol. Chem. 275,
26411–26415.
Weber-Hall, S.J., et al., 1994. Developmental and hormonal regulation of
Wnt gene expression in the mouse mammary gland. Differentiation 57,
205–214.
Wessells, N.K., Evans, J., 1968. Ultrastructural studies of early morpho-
genesis and cytodifferentiation in the embryonic mammalian pancreas.
Dev. Biol. 17, 413–446.
Whittard, J.D., et al., 2002. E-cadherin is a ligand for integrin alpha2beta1.
Matrix Biol. 21, 525–532.
Wiley, H.S., Shvartsman, S.Y., Lauffenburger, D.A., 2003. Computational
modeling of the EGF-receptor system: a paradigm for systems biology.
Trends Cell Biol. 13, 43–50.
Willert, K., et al., 2003. Wnt proteins are lipid-modified and can act as stem
cell growth factors. Nature 423, 448–452.
Wiseman, B.S., et al., 2003. Site-specific inductive and inhibitory activities
of MMP-2 and MMP-3 orchestrate mammary gland branching morpho-
genesis. J. Cell Biol. 162, 1123–1133.
Witty, J.P., Wright, J.H., Matrisian, L.M., 1995. Matrix metalloproteinases
are expressed during ductal and alveolar mammary morphogenesis, and
misregulation of stromelysin-1 in transgenic mice induces unscheduled
alveolar development. Mol. Biol. Cell. 6, 1287–1303.
Wolff, M.S., et al., 2002. Development of the rat sublingual gland: a light
and electron microscopic immunocytochemical study. Anat. Rec. 266,
30–42.
Wysolmerski, J.J., et al., 1998. Rescue of the parathyroid hormone-related
protein knockout mouse demonstrates that parathyroid hormone-related
protein is essential for mammary gland development. Development 125,
1285–1294.
Xie, W., et al., 1997. Targeted expression of a dominant negative epider-
mal growth factor receptor in the mammary gland of transgenic mice
inhibits pubertal mammary duct development. Mol. Endocrinol. 11,
1766–1781.
Yamanaka, Y., et al., 1993. Synthesis and expression of transforming
growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine
pancreas. Diabetes 42, 746–756.
Yang, Y., et al., 1995. Sequential requirement of hepatocyte growth factor
and neuregulin in the morphogenesis and differentiation of the mam-
mary gland. J. Cell Biol. 131, 215–226.
Yap, A.S., Kovacs, E.M., 2003. Direct cadherin-activated cell signaling: a
view from the plasma membrane. J. Cell Biol. 160, 11–16.
Yasuda, H., et al., 1998. Identity of osteoclastogenesis inhibitory factor
(OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/
OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139,
1329–1337.
Yeh, S., et al., 2003. Abnormal mammary gland development and growth
retardation in female mice and MCF7 breast cancer cells lacking an-
drogen receptor. J. Exp. Med. 198, 1899–1908.
Yu, W.H., et al., 2000. TIMP-3 binds to sulfated glycosaminoglycans of the
extracellular matrix. J. Biol. Chem. 275, 31226–31232.
Yu, W.H., et al., 2002. CD44 anchors the assembly of matrilysin/MMP-7
with heparin-binding epidermal growth factor precursor and ErbB4
and regulates female reproductive organ remodeling. Genes Dev. 16,
307–323.
Yurchenco, P.D., Amenta, P.S., Patton, B.L., 2004. Basement membrane
assembly, stability and activities observed through a developmental
lens. Matrix Biol. 22, 521–538.
